This is a copy of the License Agreement for Use of the UMLS® Metathesaurus® for the 2024AA Release from 05/06/2024.
To view the current license agreement, go to https://uts.nlm.nih.gov/uts/assets/LicenseAgreement.pdf . To sign up for a
UMLS license, go to https://uts.nlm.nih.gov/uts/signup-login .

License Agreement for Use of the UMLS® Metathesaurus®
This Agreement is made by and between the National Library of Medicine, Department of Health and Human Services(hereinafter referred to as "NLM") and the LICENSEE.
WHEREAS, the NLM was established by statute in order to assist the advancement of medical and related sciences, and to aid
the dissemination and exchange of scientific and other information important to the progress of medicine and to the publichealth (section 465 of the Public Health Service Act, as amended (42 U.S.C. section 286)), and to carry out this purpose has
been authorized to develop the Unified Medical Language System ® (UMLS) to facilitate the retrieval and integration ofmachine-readable biomedical information from disparate sources;
WHEREAS, the NLM's UMLS project has produced the UMLS Metathesaurus, a machine-readable vocabulary knowledge
source, that is useful in a variety of settings;
WHEREAS, the LICENSEE is willing to use the UMLS Metathesaurus at its sole risk and at no expense to NLM, which will
result in information useful to NLM, may provide immediate improvements in biomedical information transfer to segments ofthe biomedical community, and is consistent with NLM's statutory functions,
NOW THEREFORE, it is mutually agreed as follows:
1. The NLM hereby grants a nonexclusive, non-transferable right to LICENSEE to use the UMLS Metathesaurus andincorporate its content in any computer applications or systems designed to improve access to biomedical information of
any type subject to the restrictions in other provisions of this Agreement. The names and addresses of licensees
authorized to use the UMLS products are public information.
2. No charges, usage fees, or royalties will be paid to NLM.
3. LICENSEE is prohibited from distributing the UMLS Metathesaurus or subsets of it, including individual vocabularysources within the Metathesaurus, except (a) as an integral part of computer applications developed by LICENSEE for a
purpose other than redistribution of vocabulary sources contained in the UMLS Metathesaurus and (b) if permitted byparagraph 12 of this agreement.
4. LICENSEE agrees to inform NLM prior to distributing any application(s) in which it is using the UMLS Metathesaurus
and is encouraged to inform NLM of any difficulties encountered in using the UMLS Metathesaurus, and changes orenhancements to the UMLS Metathesaurus that would make it more useful to LICENSEE and its user groups.
5. Within 30 days of the end of any calendar year in which LICENSEE makes use of the UMLS Metathesaurus,
LICENSEE agrees to provide NLM with a brief report on the usefulness of the UMLS Metathesaurus in general and, if
applicable, on the usefulness of CPT in the UMLS format in particular. LICENSEE is strongly encouraged to submit to
NLM locally developed extensions to the UMLS Metathesaurus that are potentially useful to other UMLS users forconsideration for potential inclusion in the UMLS Metathesaurus.
6. NLM represents that the data provided under this Agreement were formatted with a reasonable standard of care, but
makes no warranties express or implied, including no warranty of merchantability or fitness for particular purpose,
regarding the accuracy or completeness of the data or that the machine-readable copy is error free. Therefore,
LICENSEE agrees to hold NLM, the Government, and any organization contributing a vocabulary source to the UMLS
Metathesaurus free from any liability resulting from errors in terminology or other data or on the machine-readable copy.
NLM and such other organizations disclaim any liability for any consequences due to use, misuse, or interpretation of
information contained or not contained in the UMLS Metathesaurus.

7. NLM represents that its ability to continue to include certain vocabulary sources within the UMLS Metathesaurus isdependent on continuing contractual relations or agreements with the copyright holders for these vocabulary sources.
Therefore, LICENSEE agrees to hold NLM and the individual copyright holder free from any liability resulting from theremoval of any vocabulary source from future editions of the UMLS Metathesaurus.
8. NLM reserves the right to change the type and format of its machine-readable data. NLM agrees to inform LICENSEE
of any changes to the format of the UMLS Metathesaurus, EXCEPT the addition of entirely new data elements to theMetathesaurus, at least 90 days before the data are distributed.
9. The presence in the UMLS Metathesaurus of vocabulary or data produced by organizations other than NLM does not
imply any endorsement of the UMLS Metathesaurus by these organizations.
10. LICENSEE shall acknowledge NLM as its source of the UMLS Metathesaurus, citing the year and version number, in asuitable and customary manner but may not in any way indicate or imply that NLM or any of the organizations whose
vocabulary sources are included in the UMLS has endorsed LICENSEE or its products.
11. Some of the Material in the UMLS Metathesaurus is from copyrighted sources. If LICENSEE uses any material from
copyrighted sources from the UMLS Metathesaurus:a) the LICENSEE is required to display in full, prior to providing user access to the Metathesaurus or any of the
vocabulary sources within the UMLS, the following wording in order that its users be made aware of these copyrightconstraints:"Some material in the UMLS Metathesaurus is from copyrighted sources of the respective copyright holders. Users of
the UMLS Metathesaurus are solely responsible for compliance with any copyright, patent or trademark restrictions andare referred to the copyright, patent or trademark notices appearing in the original sources, all of which are hereby
incorporated by reference.";to display a list of all of the vocabularies contained within the UMLS Metathesaurus that are used in the LICENSEE's
application; and to indicate for each vocabulary any appropriate copyright notice and whether the entire contents arepresent or only a portion of it.
b) the LICENSEE is prohibited from altering UMLS and other vocabulary source content contained within the UMLS
Metathesaurus, but may include content from other sources in applications that also contain content from the UMLS
Metathesaurus. The LICENSEE may not imply in any way that data from other sources is part of the UMLS
Metathesaurus or of any of its vocabulary sources.
c) the LICENSEE is required to include in its applications identifiers from the UMLS Metathesaurus such that theoriginal source vocabularies for any data obtained from the UMLS Metathesaurus can be determined by reference to acomplete version of the UMLS Metathesaurus.
12. For material in the UMLS Metathesaurus obtained from some sources additional restrictions on LICENSEE's use may
apply. The categories of additional restrictions are described below. The list of UMLS Metathesaurus Vocabulary
Sources, which is part of this Agreement and is updated when each version of the Metathesaurus is released, indicatesthe category of additional restrictions, if any, that apply to each vocabulary source.
LICENSEE should contact the copyright holder directly to discuss uses of a source vocabulary beyond those allowed
under this license agreement. If LICENSEE or LICENSEE's end user has a separate agreement with the copyright holder
for use of a UMLS Metathesaurus source vocabulary, LICENSEE or LICENSEE's end user may use vocabulary source
content obtained from the UMLS Metathesaurus in accordance with the terms of the separate agreement.
12. 1. Category 1:
LICENSEE is prohibited from translating the vocabulary source into another language or from producing otherderivative works based on this single vocabulary source.
12. 2. Category 2:

All category 1 restrictions AND
LICENSEE is prohibited from using the vocabulary source in operational applications that create records or information
containing data from the vocabulary source. Use for data creation research or product development is allowed.
12. 3. Category 3:
LICENSEE's right to use material from the source vocabulary is restricted to internal use at the LICENSEE's site(s) for
research, product development, and statistical analysis only. Internal use includes use by employees, faculty, andstudents of a single institution at multiple sites. Notwithstanding the foregoing, use by students is limited to doing
research under the direct supervision of faculty. Internal research, product development, and statistical analysis use
expressly excludes: use of material from these copyrighted sources in routine patient data creation; incorporation ofmaterial from these copyrighted sources in any publicly accessible computer-based information system or public
electronic bulletin board including the Internet; publishing or translating or creating derivative works from material fromthese copyrighted sources; selling, leasing, licensing, or otherwise making available material from these copyrighted
works to any unauthorized party; and copying for any purpose except for back up or archival purposes.
LICENSEE may be required to display special copyright, patent and/or trademark notices before displaying content fromthe vocabulary source. Applicable notices are included in the list of UMLS Metathesaurus Vocabulary sources, that ispart of this Agreement.
12. 4. Category 4:
12.4.1. LICENSEE is prohibited from translating the vocabulary source into another language or from altering the
vocabulary source content.
12.4.2. LICENSEE's right to use the vocabulary source is restricted to use in the U.S. by LICENSEE's employees,
contractors, faculty, students, clients, patients, or constituents within electronic systems or devices built, purchased,
licensed, or used by LICENSEE for U.S. governmental purposes or for any health care, public health, research,educational, or statistical use in the U.S. Use by students is limited to research or educational activities under the directsupervision of faculty.
12.4.3. LICENSEE has the right to distribute the vocabulary source in the U.S., but only in combination with other
UMLS Metathesaurus content. Further, LICENSEE's right to distribute is restricted to:a. Electronic distribution to LICENSEE's direct U.S. affiliates, or to other U.S. entities that have signed the UMLS
license, in order to facilitate use of the vocabulary for health care, public health, research, educational or statistical
purposes in the U.S. only.
i. LICENSEE must take reasonable precautions to prevent distribution of the vocabulary source to non-US
entities.
ii. LICENSEE must include in its annual report a list of all U.S. affiliates or other U.S. entities to whom it has
distributed content from the vocabulary source.
b. Distribution of encoded patient level data sets or knowledge encoded in the vocabulary source by LICENSEE to
any U.S. entity for use in the U.S. only.
c. Inclusion of encoded records or content from the vocabulary source in: (1) free publicly accessible retrieval
systems or (2) fee-based retrieval systems that are accessible within the U.S. only, provided that these systems do
not permit users to copy or extract any significant portion of the vocabulary source.
12.4.4. DEFINITIONS
a. U.S. is defined as all U.S. states, territories, and the District of Columbia; any U.S. government facility or office,whether permanent or temporary, wherever located; and access to a system in any of these locations by U.S.
government employees, designated representatives or contractors, wherever located, for U.S. government
purposes.
b. U.S. entity is defined as (i) for government entities, an agency or department of the U.S. Government, (ii) for
corporations, as a corporation incorporated and operating in the U.S.; and (iii) for other entities as an entity
organized under the laws of the U.S.
13. LICENSEE shall take reasonable steps to ensure that anyone who has authorized access to data or vocabulary sourcesfrom the UMLS Metathesaurus under this Agreement complies with its provisions.
14. LICENSEE and/or its end users shall be solely responsible for compliance with any copyright or other restrictions on
vocabulary sources in the UMLS Metathesaurus; NLM assumes no responsibility or liability associated with the
LICENSEE's (or any of the LICENSEE's users) use and/or reproduction of copyrighted material, patent or trademark
violations. Anyone contemplating reproduction of all or any portion of the UMLS Metathesaurus or any of its
vocabulary sources should consult legal counsel.
The holder of a copyright in any vocabulary source shall be a third party beneficiary to this agreement and shall have aright to enforce the agreement against any LICENSEE that violates any provision pertaining to that copyright holder.
15. This Agreement shall be effective until terminated by one of the parties upon 30 days written notice to the other party.
LICENSEE's failure to abide by the terms of the Agreement shall be grounds for its termination. Neither theGovernment, its employees, or any vocabulary sources contained in the UMLS Metathesaurus shall be liable or
responsible to LICENSEE in any manner whatsoever for damages of any nature whatsoever arising from the terminationof this Agreement.
16. In the event that any provision of this Agreement is determined to violate any law or is unenforceable, the remainder ofthe Agreement shall remain in full force and effect.
Please send any issues or concerns to NLM Customer Service ( https://support.nlm.nih.gov/support/create-case/ ).

APPENDIX 1
Appendix to the License Agreement for Use of the UMLS ® Metathesaurus ®
UMLS METATHESAURUS ® SOURCE VOCABULARIES - 2024AA Edition
Appendix 1 is a listing of all sources within the current version of the Metathesaurus with an indication of any additional
restrictions and notices that apply. Sources are listed in order according to the abbreviations used in the UMLS Metathesaurus
files. All sources are subject to the general terms of the License for Use of the UMLS Metathesaurus. The Categories
associated with each source are defined in the general license as follows:
Category 0 general terms of the License apply with no additional restrictions
Category 1 in addition to the general License terms, restrictions in Section 12.1 apply
Category 2 in addition to the general License terms, restrictions in Section 12.2 apply
Category 3 in addition to the general License terms, restrictions in Section 12.3 apply
Category 4 in addition to the general License terms, restrictions in Section 12.4 apply
Appendix 2 defines the terms of use of SNOMED CT. These terms take precedence over the general Metathesaurus
license terms. Where an item is not addressed in Appendix 2 the general License terms apply.
Additional Source Information: Each source includes a link to additional source information, created by NLM, describing its
purpose, content and use. The complete list of source documentation is available at:
http://www.nlm.nih.gov/research/umls/sourcereleasedocs/index.html . Additional documentation may also be available fromthe producers of the source. Contact information is provided for each source.
Questions Regarding Additional Permissions or License Agreements: Questions about uses not covered by thisAgreement, or other inquiries about individual sources, should be directed to the source contact.
AIR93 - ;;;;AI/RHEUM;;;;;National Library of Medicine, Lister Hill Center;1993;;Bethesda, MD;;;;;;
Contact: May Cheh;;Lister Hill National Center for Biomedical Communications, National Library of Medicine;Building 38A,
Room 9E902;8600 Rockville Pike;Bethesda;MD;;20894;;; cheh@nlm.nih.gov ;Read more information about this source
ALT2009 - ;;;;ABC Codes and Terminology;;;9th;Albuquerque, NM;ABC Coding Solutions - Alternative
Link;2009;;;;;;ENG;;
CATEGORY 3 RESTRICTIONS APPLYContact: ;;ABC Coding Solutions - Alternative Link;6121 Indian School Road NE;Suite 131;Albuquerque;NM;UnitedStates;87110;1-877-621-5465;1-505-875-0002; Legal@ABCcodes.com ;Read more information about this source
AOD2000 - ;;;;Alcohol and Other Drug Thesaurus: A Guide to Concepts and Terminology in Substance Abuse andAddiction;;;3rd. ed. [4 Volumes.];Bethesda, MD;National Institute on Alcohol Abuse and Alcoholism (NIAAA) and Center for
Substance Abuse Prevention (CSAP);2000;;;;;;ENG;;
Contact: Nancy Winstanley;;NIAAA Library c/o CSR Incorporated;2107 Wilson Blvd., Suite
1000;;Arlington;VA;;22201;703-741-7147;; e-mail: nwinstanley@csrincorporated.com ;;Read more information about this source
AOT2003 - ;;;;Authorized Osteopathic Thesaurus;;;;Chevy Chase, MD;Educational Council of Osteopathic Principles of theAmerican Association of Colleges of Osteopathic Medicine;2004;;;;;
http://www.aacom.org/InfoFor/educators/Pages/thesaurus.aspx ;ENG;;
Contact: ;;;;;Chevy Chase;MD;;;;;; http://www.aacom.org/InfoFor/educators/Pages/thesaurus.aspx
Read more information about this source
ATC_2024_01_19_24_03_04 (updated) - ;;WHO Collaborating Centre for Drug Statistics Methodology;;Anatomical
Therapeutic Chemical (ATC) classification system;;;2022;Oslo, Norway;WHO Collaborating Centre for Drug Statistics
Methodology;;;;;; http://www.whocc.no/copyright_disclaimer/ ;;;Contact: ;;WHO Collaborating Centre for Drug Statistics Methodology;Norwegian Institute of Public Health;P.O.Box 4404
Nydalen;Oslo;;Norway;0403;+47 21 07 81 60;+47 21 07 81 46; whocc@fhi.no ; http://www.whocc.no/copyright_disclaimer/
Read more information about this source
BI98 - Howard Goldberg, MD;;;;Beth Israel OMR Clinical Problem List Vocabulary;;;Version 1.0;Boston, MA;Beth Israel
Deaconess Medical Center;1999;;;;;;ENG;;
CATEGORY 2 RESTRICTIONS APPLYContact: Daniel Z. Sands, M.D., M.P.H.;Clinical Systems Integration Architect;Center for Clinical Computing,Beth Israel
Deaconess Medical Center,Harvard University;330 Brookline Avenue;;Boston;MA;United States;02215;617-667-1510;810592-0716; e-mail: dsands@bidmc.Harvard.edu ;Read more information about this source
CCC2_5_2018 - ;;SabaCare,Inc.;;Clinical Care Classification (CCC) System;;;2.5;;;;January 10, 2018;;;;;ENG;;
CATEGORY 1 RESTRICTIONS APPLYContact: Dr. Virginia K. Saba;CEO & President;SabaCare,Inc;;;Arlington;VA;United States;;703-521-6132;703-521-3866;vsaba@att.net ; http://www.sabacare.com/ ;Read more information about this source
CCPSS99 - ;;;;Canonical Clincial Problem Statement System;;;Version 1.0;;;June 23, 1999;;;;;;ENG;Contact:sbrown@vumclib.mc.vanderbilt.edu ;CATEGORY 3 RESTRICTIONS APPLY
Permission will be freely given for any uses and applications containing CCPSS which are not for sale - i.e. those usedinternally or given to others without charge.
Contact: Steven Brown, M.D.;Associate Professor, Biomedical Informatics;Eskind Biomedical Library, Vanderbilt University
Medical Center;2209 Garland Ave;Room 442;Nashville;TN;United States;37232-8340;(615) 321-6335;;
sbrown@vumclib.mc.vanderbilt.edu ;Read more information about this source
CCS2005 - ;;Agency for Healthcare Research and Quality (AHRQ);;Clinical Classifications Software (CCS);;;;;;April
2005;;Rockville,MD;;; http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp ;ENG;Phone: 301-594-1364.;
Contact: Anne Elixhauser, Ph.D.;Senior Research Scientist;Agency for Healthcare Research and Quality;540 Gaither
Road;;Rockville;MD;United States;20850;(301) 427-1411, 1-800-358-9295;(301) 594-1430; AElixhau@AHRQ.gov ;Read more information about this source
CCSR_ICD10CM_2024 (updated) - ;;Healthcare Cost and Utilization Project (HCUP);;Clinical Classifications Software
Refined for ICD-10-CM;;;;;Agency for Healthcare Research and Quality (AHRQ);;February 2024;Rockville, MD;;;;ENG;;
Contact: ;;Agency for Healthcare Research and Quality;5600 Fishers Lane;Mail Stop 07N94A;Rockville;MD;UnitedStates;20857;1-866-290-HCUP;(301) 594-1430; hcup@ahrq.gov ;https://www.hcupus.ahrq.gov/toolssoftware/ccsr/ccs_refined.jsp;
Read more information about this source
CCSR_ICD10PCS_2024 (updated) - ;;Healthcare Cost and Utilization Project (HCUP);;Clinical Classifications Software
Refined for ICD-10-PCS;;;;;Agency for Healthcare Research and Quality (AHRQ);;February 2024;Rockville, MD;;;;ENG;;
Contact: ;;Agency for Healthcare Research and Quality;5600 Fishers Lane;Mail Stop 07N94A;Rockville;MD;UnitedStates;20857;1-866-290-HCUP;(301) 594-1430; hcup@ahrq.gov ;https://www.hcupus.ahrq.gov/toolssoftware/ccsr/ccs_refined.jsp;
Read more information about this source

CDCREC_1.2 - ;;CDC, National Center for Health Statistics;;Race & Ethnicity - CDC;;;;Atlanta, GA;;;December 27,
2017;;;;;;;
Contact: ;;CDC, National Center for Health Statistics;1600 Clifton Road;Mailstop: E-62;Atlanta;GA;United States;30333;;;;
http://www.cdc.gov/phin/resources/vocabulary/index.html ;Read more information about this source
CDT2023 - ;;;;Code on Dental Procedures and Nomenclature;;;2023;Chicago, IL;American Dental Association;;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYFor CDT the following special notice must be displayed:"For CDT only, copyright 2021 American Dental Association, all rights reserved."
Contact: Debbie Labinger;Manager, Special Accounts Senior Manager, Special Accounts and Licensing Program;American
Dental Association;211 East Chicago Ave.;;Chicago;IL;United States;60611-2678;312-440-7742;; LabingerD@ada.org;https://www.ada.org/publications/CDT;
Read more information about this source
CHV2011_02 - ;;;;Consumer Health Vocabulary;;;;;;;2011;USA;;;;ENG;;
Contact: Qing Zeng, PhD;;Biomedical Informatics Department, University of Utah;26 South 2000 East Room 5775
HSEB;;Salt Lake City;UT;USA; 84112;;; q.t.zeng@utah.edu ;Read more information about this source
COSTAR_89-95 - ;;;;Computer-Stored Ambulatory Records (COSTAR);;;;Boston, MA;Massachusetts General
Hospital;1989-1995;;;;;;ENG;;
The UMLS Metathesaurus includes terms that were used frequently at 3 COSTAR sites in the years indicated and supplied to
NLM by Massachusetts General Hospital.
Contact: G.Octo Barnett, M.D.;;Laboratory of Computer Science Massachusetts General Hospital;50 Staniford Street, 5thFloor;;Boston;MA;United States;02114;(617) 726-3939;(617) 726-8481; e-mail: Barnett.Octo@mgh.harvard.edu ;Read more information about this source
CPM2003 - ;;;;Medical Entities Dictionary (CPM);;;;New York (NY);Columbia Presbyterian Medical Center;2003;;;;;;ENG;;
CATEGORY 2 RESTRICTIONS APPLYThe UMLS Metathesaurus includes a relatively small number of terms created at Columbia Presbyterian Medical Center for
the MED, which also includes terms obtained from the UMLS Metathesaurus and other sources.
Contact: George Hripcsak, M.D.;Professor and Chair;Department of Biomedical Informatics, Vanderbilt Clinic VC5;Columbia University;622 W. 168th Street;New York ;New York;USA;10032;(212) 305-5780;(212) 305-3302;
kripcsak@columbia.edu ;Read more information about this source

CPT2024 (updated) - ;;;;Current Procedural Terminology (CPT);;;;;American Medical Association;;2024;Chicago, IL;;;;;;CATEGORY 3 RESTRICTIONS APPLY
The following special notice must be displayed:"CPT™ only Copyright 2021 American Medical Association. All rights Reserved. No fee schedules, basic unit, relative values
or related listings are included in CPT™. AMA does not directly or indirectly practice medicine or dispense medical services.
AMA assumes no liability for data contained herein.
U.S. Government Rights
This product includes CPT™ which is commercial technical data and/or computer data bases and/or commercial computer
software and/or commercial computer software documentation, as applicable which were developed exclusively at private
expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60610. U.S. Government rights touse, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer
software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2)(June 1995) and/or subject to the restrictions of DFARS 227.7202-1(a) (June 1995) and DFARS 227.7202-3(a) (June 1995), as
applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987)
and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable,
and any applicable agency FAR Supplements, for non-Department of Defense Federal procurements."
Contact: ;;American Medical Association;330 N. Wabash, Suite 39300;;Chicago;IL;United States;60611;(800) 621-8335;;
Intellectual.PropertyServices@ama-assn.org ;https://www.ama-assn.org/practice-management/cpt-current-proceduralterminology;
Read more information about this source
CPT01SP - ;;;;Current Procedural Terminology (CPT), Spanish Translation;;;4th ed;Chicago (IL);American Medical
Association;2000;;;;; http://www.ama-assn.org .;ESP;;CATEGORY 3 RESTRICTIONS APPLYContact: Dorith Brown;;CPT Intellectual Property Services,American Medical Association;515 N. State
Street;;Chicago;IL;United States;60610;;(312) 464-5762;;
Read more information about this source
CSP2006 - ;;;Computer Retrieval of Information on Scientific Projects (CRISP);;;;;Bethesda (MD);National Institutes of
Health, Division of Research Grants, Research Documentation Section;2006;;;;;;;;
Contact: Dorrette Finch;Director;Division of Research Documentation, ORA, OER, National Institutes of Health;6701
Rockledge Drive;;Bethesda;MD;;20892-7983;;; dw33v@nih.gov ;Read more information about this source
CST95 - ;;;;Coding Symbols for Thesaurus of Adverse Reaction Terms (COSTART);;;5th ed;Rockville (MD);U.S. Food andDrug Administration, Center for Drug Evaluation and Research;1995;;;;;;;;COSTART has been superseded by the Medical Dictionary for Regulatory Activities (MedDRA) Terminology.
Contact: ;;National Technical Information Service ;;;;;;;;;; http://www.ntis.gov/fcpc/cpn5580.htm
Read more information about this sourceCVX_2024_02_15 (updated) - ;;National Center for Immunization and Respiratory Diseases;;CVX Code Set;;;;Atlanta,
GA;;;October 11, 2023;;;;;;;
Contact: ;;CDC, National Center for Immunization and Respiratory Diseases Immunization Information System Support
Branch - Informatics;1600 Clifton Road;Mailstop: E-62;Atlanta;GA;United States;30333;;; iisinfo@cdc.gov ;http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx ;Read more information about this source
DDB00 - Malcolm Duncan;;;;Diseases Database 2000;;;;London (England);Medical Object Oriented Software Enterprises
Ltd.;2000;May, 2000;;;; http://www.diseasesdatabase.com/ ;;;CATEGORY 3 RESTRICTIONS APPLYContact: Malcolm H. Duncan;;Medical Object Oriented Software Enterprises Ltd;Unit 36c Marryat
Square;Fulham;London;;UK;SW6 6UA;44 (0)20 7381 4220 Mobile: 07710 483088;; mhduncan@compuserve.com ;http://www.diseasesdatabase.com/
Read more information about this source
DMDICD10_1995 - ;;;;Internationale Klassifikation der Krankheiten 10 [German translation of ICD10];;;;Germany;Deutsches
Institut fuer Medizinische Dokumentation und Information;1998;;;;;;;;CATEGORY 1 RESTRICTIONS APPLYContact: Dr. Michael Schopen;; Deutsches Institut fur Medizinische Dokumentation und Information (DIMDI);Postfach
420580, D-50899 ;;Koln;;Germany;;49-221-472-4252;49-221-41-1429; schopen@dimdi.de ;Read more information about this source
DMDUMD_1996 - ;;;;Die Nomenklatur fuer Medizinprodukte UMDNS [German translation of
UMDNS];;;;Germany;Deutsches Institut fuer Medizinische Dokumentation und Information;1996;;;;;;;;CATEGORY 1 RESTRICTIONS APPLYContact: Dr. Michael Schopen;;Deutsches Institut fur Medizinische Dokumentation und Information (DIMDI);Postfach
420580, D-50899;;Koln;;Germany;;49-221-472-4252;49-221-41-1429; helpdesk@dimdi.de ;www.dimdi.de
Read more information about this source
DRUGBANK5.0_2024_02_09 (updated) - ;;;;DrugBank;;;5.0;;OMx Personal Health Analytics Inc.;;February 09,2024;Edmonton, Alberta, Canada;;;;;Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z,
Woolsey J. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006 Jan 1
34(Database issue):D668-72.;
Contact: ;;OMx Personal Health Analytics Inc.;301 - 10359 104 St.;;Edmonton;Alberta;Canada;T5J 1B9;312-440-7742;;
support@omx.io ; http://www.drugbank.ca ;Read more information about this source
DSM-5_2015 - ;;;;Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5);;;5;Arlington, VA;American
Psychiatric Association (APA);2013;2015;;;; http://www.dsm5.org/Pages/PermissionsPolicy.aspx ;;Reprinted with permission
from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Copyright 2013. American Psychiatric
Association. All Rights Reserved. Unless authorized in writing by the APA, no part may be reproduced or used in a mannerinconsistent with the APA's copyright. This prohibition applies to unauthorized uses or reproductions in any form. The
American Psychiatric Association is not affiliated with and is not endorsing this product.;
CATEGORY 3 RESTRICTIONS APPLYContact: ;;American Psychiatric Association;1000 Wilson Boulevard;Suite 1825;Arlington;VA;USA;22209-3901;703-9077300;; apa@psych.org ; http://www.dsm5.org/ ;Read more information about this source
DXP94 - ;;;;DXplain (An expert diagnosis program);;;;Boston (MA);Massachusetts General Hospital;1994;;;;;;;;
Contact: G. Octo Barnett, M.D.;;Laboratory of Computer Science, Massachusetts General Hospital;50 Staniford Street;5th
Floor;Boston;MA;;02114;(617) 726-3939;(617) 726-8481; Barnett.Octo@mgh.Harvard ;Read more information about this source
FMA4_15 - Jose Leonardo V. Mejino Jr., M.D., Cornelius Rosse, M.D., DSc;;;;Foundation Model of
Anatomy;;;v4.15.0;Department of Biological Structure, University of Washington;;;April 2019;;;;;;;
Contact: Jose L. V Mejino Jr. MD;Senior Scientist, Project Director and Curator of FMA;Department of Biological Structure,
University of Washington;1959 NE Pacific Street;Box 357420;Seattle;WA;United States;98195;206-543-7118;206-543-1524;
fma@sig.biostr.washington.edu ; http://si.washington.edu/projects/fma ;Read more information about this source
GO2023_05_10 - ;;;;Gene Ontology;;;;;Gene Ontology Consortium;;May 10, 2023;;;;;;;
Contact: ;;Gene Ontology Consortium;;;;;;;;;https://github.com/geneontology/helpdesk/issues; http://www.geneontology.org/ ;Read more information about this source
GS_2024_02_12 (updated) - ;;;;Gold Standard Drug Database;;;;302 Knights Run Ave, Suite 800, Tampa, FL 33602;GoldStandard;;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: RxNorm Customer Service;;U.S. National Library of Medicine;8600 Rockville Pike;;Bethesda;MD;UnitedStates;20894;(888) FIND-NLM;; rxnorminfo@nlm.nih.gov ;https://www.nlm.nih.gov/research/umls/rxnorm/
Read more information about this source
HCDT2023 - ;;;;HCPCS Version of Current Dental Terminology;;;;Baltimore, MD;Centers for Medicare & Medicaid
Services;2023;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Cynthia Hake;CMS HCPCS Workgroup Chair;Centers for Medicare & Medicaid Services (CMS);7500 Security
Boulevard;;Baltimore;MD;United States;21244;1-410-786-3404;; hcpcs@cms.hhs.gov;https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/index.html;
Read more information about this source

HCPCS2024 (updated) - ;;;;Healthcare Common Procedure Coding System (HCPCS);;;;Baltimore, MD;Centers for Medicare& Medicaid Services;2024;;;;;;;;The American Medical Association's CPT™ codes in HCPCS have a Source Abbreviation of HCPT04. The American Dental
Association's CDT codes in HCPCS have a Source Abbreviation of HCDT4.
Contact: Cynthia Hake;CMS HCPCS Workgroup Chair;Centers for Medicare & Medicaid Services (CMS);7500 Security
Boulevard;;Baltimore;MD;United States;21244;1-410-786-3404;; hcpcs@cms.hhs.gov;https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/index.html;
Read more information about this source
HCPT2024 (updated) - ;;;;Version of Physicians' Current Procedural Terminology (CPT) included in the Healthcare Common
Procedure Coding System (HCPCS);;;;Baltimore, MD;Centers for Medicare & Medicaid Services;2024;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Cynthia Hake;CMS HCPCS Workgroup Chair;Centers for Medicare & Medicaid Services (CMS);7500 Security
Boulevard;;Baltimore;MD;United States;21244;1-410-786-3404;; hcpcs@cms.hhs.gov;https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/index.html;
Read more information about this source
HGNC2023_04 - Gray KA, Yates B, Seal RL, Wright MW, Bruford EA;;HGNC Database;;The HUGO Gene Nomenclature
Database;;;;European Bioinformatics Institute Wellcome Trust Genome Campus;;;April 21, 2023;United Kingdom;;;;;;
Contact: Elspeth Bruford, PhD;Group Co-ordinator;HUGO Gene Nomenclature Committee (HGNC);European Bioinformatics
Institute (EMBL-EBI);Wellcome Trust Genome Campus;Hinxton;Cambridge;United Kingdom;CB10 1SD;;+44 (0) 1223 494
468; hgnc@genenames.org ;https://www.genenames.org/;
Read more information about this source
HL7V2.5_2003_08_30 - Mark McDougall, Executive Director, Health Level Seven; 3300 Washtenaw Avenue, Suite 227,
Ann Arbor, MI 48104-4250;;;Health Level Seven Vocabulary (HL7);;;;Ann Arbor (MI);;1998-2002;;;;;www.HL7.ORG;;;
Contact: Health Level Seven;;;3300 Washtenaw Avenue,;Suite 227;Ann Arbor;MI;;48104-4250;(734)677-7777;(734)6776622; HQ@HL7.ORG ;Read more information about this source
HL7V3.0_2023_11 (updated) - ;;;;Health Level Seven (HL7) Vocabulary;;;;Ann Arbor, MI;;;November 17, 2023;;;;
http://www.hl7.org/ ;;;Contact: Health Level Seven International;;;3300 Washtenaw Avenue;Suite 227;Ann Arbor;MI;USA;48104-4250;(734)6777777;(734)677-6622; HQ@HL7.ORG ;;Read more information about this source
HLREL_1998 - Dr. Henk Lamberts;;University of Amsterdam;;ICPC2E-ICD10 relationships from (HLREL);;;;;;1998;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Henk Lamberts;;University of Amsterdam;;;;;;;;; H.Lamberts@AMC.UVA.NL ;Read more information about this source
HPO2023_10_09 (updated) - ;;;;The Human Phenotype Ontology (HPO);;;;;The Human Phenotype Ontology
Consortium;;October 9, 2023;;;;;;;
Contact: Dr. Peter N. Robinson;Professor of Computational Biology;The Jackson Laboratory for Genomic Medicine;10
Discovery Drive;;Farmington;CT;;06032;860.837.2095 t, 860.990.3130 m;; peter.robinson@jax.org;https://hpo.jax.org/app/contact;
Read more information about this source
ICD10_1998 - ;;;;International Statistical Classification of Diseases and Related Health Problems (ICD-10);;;10th rev.;Geneva(Switzerland);World Health Organization;1998;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;Office of Publications, World Health Organization;1211 Geneva 27;;;;Switzerland;;;;;
Read more information about this source
ICD10_2016 - ;;;;International Statistical Classification of Diseases and Related Health Problems (ICD-10);;;Tenth
Revision;Geneva, Switzerland;World Health Organization;2016;;;;;;ENG;;
CATEGORY 3 RESTRICTIONS APPLYContact: ;Office of Publications;World Health Organization;;;Geneva;;Switzerland;1211 Geneva 27;;; bookorders@who.int ;http://www.who.int/about/en/ ;Read more information about this source
ICD10AE_1998 - ;;;;International Statistical Classification of Diseases and Related Health Problems (ICD-10): AmericanizedVersion.;;;10th rev.;Geneva (Switzerland);World Health Organization;1998;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;Office of Publications, World Health Organization;1211 Geneva 27;;;;Switzerland;;;;;
Read more information about this source
ICD10AM_2000 - ;;National Centre for Classification in Health, University of Sydney, Faculty of Health
Sciences;;International Statistical Classification of Diseases and Related Health Problems, 10th Revision, AustralianModification;;;2nd Edition;;;January 2000;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;National Centre for Classification in Health, University of Sydney, Faculty of Health Sciences;PO Box
170;;Lidcombe;NSW;Australia;1825;+61 2 9351 9461;; D.Truran@cchs.usyd.edu.au ;Read more information about this source
ICD10AMAE_2000 - ;;;;International Statistical Classification of Diseases and Related Health Problems, AustralianModification (ICD-10-AM), Americanized English Equivalents;;;;Bethesda (MD);National Library of Medicine;2000;;;;;;;;

CATEGORY 3 RESTRICTIONS APPLYContact: ;;National Centre for Classification in Health University of Sydney Faculty of Health Sciences;PO Box
170;;Lidcombe;NSW;Australia;1825;+61 2 9351 9461;;;
Read more information about this source
ICD10CM_2024 - ;;National Center for Health Statistics (NCHS), under authorization by the World HealthOrganization;;ICD-10-CM: International Classification of Diseases, Tenth Revision, Clinical Modification;;;;UnitedStates;;2024;;;;;;;;CATEGORY 4 RESTRICTIONS APPLY to U.S. UMLS USERS
CATEGORY 3 RESTRICTIONS APPLY to Non-U.S. UMLS USERS
Contact: Donna Pickett;Medical Classification Administrator;National Center for Health Statistics;3311 Toledo
Road;;Hyattsville;MD;United States;20782;1-800-232-4636;; nchsicd10cm@cdc.gov ;https://www.cdc.gov/nchs/icd/icd-10cm.htm;
Read more information about this source
ICD10DUT_200403 - Hirs, W., H.W. Becker, C. van Boven, S.K. Oskam, I.M. Okkes, H. Lamberts;;;;ICD-10, Dutch
Translation;;;;Amsterdam;Department of General Practice, Academic Medical Center/University of Amsterdam, Dutch
College of General Practitioners (NHG);March 2004;200403;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICD10PCS_2024 - ;;Centers for Medicare and Medicaid Services;;International Classification of Diseases, 10th Revision,
Procedure Coding System;;;;Baltimore, MD;;2024;;;;;;;;
Contact: Pat Brooks;Senior Technical Advisor;Center for Medicare and Medicaid Services;7500 Security Blvd. C4-0806;;Baltimore;MD;United States;21244;;; patricia.brooks2@cms.hhs.gov;https://www.cms.gov/Medicare/Coding/ICD10/index.html;
Read more information about this source
ICD9CM_2014 - ;;National Center for Health Statistics (NCHS);;ICD-9-CM: International Classification of Diseases, Ninth
Revision, Clinical Modification;;;FY 2014 Medicare Addendum;United States;;October 1, 2013;;Baltimore, MD;;;;;;
NLM has generated fully specified titles for ICD-9-CM codes in cases in which the official ICD- 9-CM titles consist ofextensions to higher levels in the ICD-9-CM hierarchy. The fully specified names were produced with reasonable care, buthave not yet been reviewed and approved by the producers of ICD-9-CM.
Contact: Patricia Brooks;Contact for Procedures;Health Care Financing Administration;Centers for Medicare & Medicaid
Services;7500 Security Boulevard;Baltimore;MD;United States;21244;;; pbrooks@hcfa.gov ; http://www.cms.hhs.gov/
Read more information about this source
ICD9CM_2005 - ICD-9-CM [computer file]: international classification of diseases, ninth revision, clinical modification.
Version 22. Baltimore, MD: U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services,effective October 1, 2004.
NLM has generated fully specified titles for ICD-9-CM codes in cases in which the official ICD- 9-CM titles consist ofextensions to higher levels in the ICD-9-CM hierarchy. The fully specified names were produced with reasonable care, buthave not yet been reviewed and approved by the producers of ICD-9-CM.
Contact: Contact for Diseases: Donna Pickett, National Center for Health Statistics; e-mail: dfp4@cdc.gov ; Contact for
Procedures: Patricia Brooks, Health Care Financing Administration; e-mail: pbrooks@hcfa.gov ;Read more information about this source
ICF_2008_12_19 - ;;World Health Organization;;International Classification of Functioning, Disability and Health;;;;Geneva,
Switzerland;World Health Organization;2008;12/19/2008;;;; http://www.who.int/classification/icf ;;;CATEGORY 4 RESTRICTIONS APPLY to U.S. UMLS USERS
CATEGORY 3 RESTRICTIONS APPLY to Non-U.S. UMLS USERS
Contact: Nenad Kostanjsek;Technical Officer, Classification, Terminology and Standards (CTS), Department of Health
Statistics and Informatics (HSI);World Health Organization;20, Avenue Appia;;CH-1211 Geneva
27;;Switzerland;;+41.22.791.3242;+41.22.791.4894; kostanjsekn@who.int ; http://www.who.int/classification/icf ;Read more information about this source
ICF-CY_2008 - ;;World Health Organization;;International Classification of Functioning, Disability and Health for Children
and Youth;;;;Geneva, Switzerland;World Health Organization;2008;;;;; http://www.who.int/classification/icf ;;;CATEGORY 4 RESTRICTIONS APPLY to U.S. UMLS USERS
CATEGORY 3 RESTRICTIONS APPLY to Non-U.S. UMLS USERS
Contact: Nenad Kostanjsek;Technical Officer, Classification, Terminology and Standards (CTS), Department of Health
Statistics and Informatics (HSI);World Health Organization;20, Avenue Appia;;CH-1211 Geneva
27;;Switzerland;;+41.22.791.3242;+41.22.791.4894; kostanjsekn@who.int ; http://www.who.int/classification/icf
Read more information about this source
ICNP_2022 - ;;International Council of Nurses;;International Classification for Nursing Practice (ICNP);;;2022;Geneva,
Switzerland;International Council of Nurses;2022;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Asta Steinunn Thoroddsen;;;;;;;;;;; icnp@icn.ch ;https://www.icn.ch/what-we-do/projects/ehealth-icnp;
Read more information about this source
ICPC93 - ;;;;The International Classification of Primary Care (ICPC);;;;Denmark;World Organisation of Family
Doctors;1993;;;;;;;;
This year, the Metathesaurus has also included translations of ICPC93 in the following languages:
Basque (ICPCBAQ_1993),
Danish (ICPCDAN_1993),
Dutch (ICPCDUT_1993),
Finnish (ICPCFIN_1993),

French (ICPCFRE_1993),
German (ICPCGER_1993),
Hebrew (ICPCHEB_1993),
Hungarian (ICPCHUN_1993),
Italian (ICPCITA_1993),
Norwegian (ICPCNOR_1993),
Portuguese (ICPCPOR_1993),
Spanish (ICPCSPA_1993), andSwedish (ICPCSWE_1993).
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPC2EDUT_200203 - Hirs, W., H.W. Becker, C. van Boven, S.K. Oskam, I.M. Okkes, H. Lamberts.;;;;International
Classification of Primary Care 2E: 2nd ed. electronic. Dutch Translation;;;2nd ed. ;Amsterdam;Department of General
Practice, Academic Medical Center/University of Amsterdam, Dutch College of General Practitioners (NHG);March
2002;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPC2EENG_200203 - ;;Classification Committee of the World Organization of National Colleges, Academies andAcademic Associations of General Practitioners/Family Physicians (WONCA), known more briefly as the World Organizationof Family Doctors;Henk Lamberts and Inge Hofmans-Okkes;International Classification of Primary Care;;;2nd ed.;;World
Organization of Family Doctors;2002;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPC2ICD10DUT_200412 - ;;Classification Committee of the World Organization of National Colleges, Academies andAcademic Associations of General Practitioners/Family Physicians (WONCA), known more briefly as the World Organizationof Family Doctors;Henk Lamberts and Inge Hofmans-Okkes;International Classification of Primary Care, Dutch
Translation;;;2nd ed.;;World Organization of Family Doctors;2002;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPC2ICD10ENG_200412 - ;;Classification Committee of the World Organization of National Colleges, Academies andAcademic Associations of General Practitioners/Family Physicians (WONCA), known more briefly as the World Organizationof Family Doctors;Henk Lamberts and Inge Hofmans-Okkes;International Classification of Primary Care;;;2nd ed;;World
Organization of Family Doctors;2002;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPC2P_2005 - ;;;;ICPC-2 PLUS;;;;Sydney;Family Medicine Research Centre, University of Sydney;December 2005;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: A/Prof Helena Britt;Director, Family Medicine Research Centre, Acacia House, Westmead Hospital;;PO Box533;;Wentworthville;NSW;Australia;2145;+61 2 9845 8150;+612 9845 8155; fmrc@fmrc.org.au ; http://www.fmrc.org.au/
Read more information about this source
ICPCBAQ_1993 - ;;;;The International Classification of Primary Care (ICPC). Basque Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPCDAN_1993 - ;;;;The International Classification of Primary Care (ICPC). Danish Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPCDUT_1993 - ;;;;The International Classification of Primary Care (ICPC). Dutch Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPCFIN_1993 - ;;;;The International Classification of Primary Care (ICPC). Finnish Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support; ;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPCFRE_1993 - ;;;;The International Classification of Primary Care (ICPC). French Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPCGER_1993 - ;;;;The International Classification of Primary Care (ICPC). German Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPCHEB_1993 - ;;;;The International Classification of Primary Care (ICPC). Hebrew Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPCHUN_1993 - ;;;;The International Classification of Primary Care (ICPC). Hungarian Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPCITA_1993 - ;;;;The International Classification of Primary Care (ICPC). Italian Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPCNOR_1993 - ;;;;The International Classification of Primary Care (ICPC). Norwegian Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPCPOR_1993 - ;;;;The International Classification of Primary Care (ICPC). Portuguese Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPCSPA_1993 - ;;;;The International Classification of Primary Care (ICPC). Spanish Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
ICPCSWE_1993 - ;;;;The International Classification of Primary Care (ICPC). Swedish Translation.;;;;Denmark;World
Organisation of Family Doctors;1993;;;;;;;;
Contact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source

JABL99 - ;;;;Online Congenital Multiple Anomaly/Mental Retardation Syndromes;;;;;;1999;;;;;;;;CATEGORY 1 RESTRICTIONS APPLYContact: UMLS Support;;National Library of Medicine;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
KCD5_2008 - ;;;;Korean Standard Classification of Disease Version 5;;;;Seoul, Korea;;2008;2008;Seoul, Korea;;;;KOR;;
CATEGORY 3 RESTRICTIONS APPLYContact: Bo-Young Jung;;Korea Centers for Disease Control and Prevention;;;;;Korea;;+82-2-3481-6791;+82-2-532-3820;
happiness630@hanmail.net ;Read more information about this source
LCH90 - ;;;;Library of Congress Subject Headings;;;12th ed.;Washington (DC);Library of Congress;1989;;;;;;;;
There are later editions of this source that are not reflected in the UMLS Metathesaurus. This source has considerable nonbiomedical content and will never be included in the Metathesaurus in its entirety.
Contact: ;;;;;;;;;;;; http://www.lcweb.loc.gov
Read more information about this source
LCH_NW_2013 - ;;Northwestern University Library;;Library of Congress Subject Headings, Northwestern University
subset;;;;Evanston, IL;;;2013;;;;;;;
Contact: Gary L. Strawn;Authorities Librarian;Northwestern University Library;1970 Campus Drive;;Evanston;IL;UnitedStates;60208-2300;(847)491-2788;(847)491-8306; mrsmith@northwestern.edu;https://galter.northwestern.edu/About%20us/northwestern-university-libraries-lcsh-mesh-mapping-project;
Read more information about this source
LNC277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC);;;Version
2.77;Indianapolis (IN);;February 27, 2024;;;;;;;;
The following special notice must be displayed:"This product includes all, or a portion of, or is derived from content from LOINC that is subject to a license from Regenstrief
Institute, Inc. Your use of LOINC content also is subject to this license, a copy of which is available https://loinc.org/license/ .
The current complete LOINC distribution is available for download at http://loinc.org . The LOINC Table and LOINC codes
are copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC)
Committee. The LOINC Table, LOINC Table Core, LOINC Panels and Forms File, LOINC Answer File, LOINC Part File,
LOINC Group File, LOINC Document Ontology File, LOINC Hierarchies, LOINC Linguistic Variants File, LOINC/RSNARadiology Playbook, LOINC/IEEE Medical Device Code Mapping Table, LOINC Display Name File, LOINC Consumer
Name File, and LOINC Change Snapshot File are copyright © 1995-2020, Regenstrief Institute, Inc. All rights reserved. THE
LOINC TABLE (IN ALL FORMATS), LOINC TABLE CORE, LOINC PANELS AND FORMS FILE, LOINC ANSWER
FILE, LOINC PART FILE, LOINC GROUP FILE, LOINC DOCUMENT ONTOLOGY FILE, LOINC HIERARCHIES,
LOINC LINGUISTIC VARIANTS FILE, LOINC/RSNA RADIOLOGY PLAYBOOK, LOINC/IEEE MEDICAL DEVICE
CODE MAPPING TABLE, LOINC DISPLAY NAME FILE, LOINC CONSUMER NAME FILE, AND LOINC CHANGE
SNAPSHOT FILE ARE PROVIDED "AS IS." ANY EXPRESS OR IMPLIED WARRANTIES ARE DISCLAIMED,INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FORA PARTICULAR PURPOSE. LOINC® is a registered United States trademark of Regenstrief Institute, Inc. A small portionof LOINC content may include content (e.g., survey instruments) that is subject to copyrights owned by third parties. Suchcontent has been mapped to LOINC terms under applicable copyright and terms of use. Notice of such third-party copyrightand license terms would need to be included if such content is included."
The LOINC/RSNA Radiology Playbook and the LOINC Part File contain content from RadLex® ( http://www.radlex.org ),copyright © 2005-2019, The Radiological Society of North America, Inc., available at no cost under the license at
http://www.rsna.org/uploadedFiles/RSNA/Content/Informatics/RadLex_License_Agreement_and_Terms_of_Use_V2_Final.pdf.
The LOINC/IEEE Medical Device Code Mapping Table contains content from IEEE ( http://ieee.org ), copyright © 2019
IEEE.
This product includes all or a portion of the UCUM table, UCUM codes, and UCUM definitions or is derived from it, subject
to a license from Regenstrief Institute, Inc. and The UCUM Organization. Your use of the UCUM table, UCUM codes, UCUM
definitions also is subject to this license, a copy of which is available at http://unitsofmeasure.org . The current complete
UCUM table, UCUM Specification are available for download at http://unitsofmeasure.org . The UCUM table and UCUM
codes are copyright © 1995-2020, Regenstrief Institute, Inc. and the Unified Codes for Units of Measures (UCUM)
Organization. All rights reserved. THE UCUM TABLE (IN ALL FORMATS), UCUM DEFINITIONS, AND
SPECIFICATION ARE PROVIDED "AS IS." ANY EXPRESS OR IMPLIED WARRANTIES ARE DISCLAIMED,INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR
A PARTICULAR PURPOSE.
Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street;;Indianapolis;IN;UnitedStates;46202;(317) 274-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-DE-AT_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
German, Austria Edition;;;Version 2.77;Austria;ELGA;February 27, 2024;;;;;;German;;Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-DE-DE_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
German, Germany Edition;;;Version 2.77;Germany;Institute for Medical Documentation and Information (DIMDI);February
27, 2024;;;;;;German;;Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-EL-GR_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
Greek, Greece Edition;;;Version 2.77;Greece;Efstratia Kontaxi, MD, MSc, and Evripidis Stefanidis, MD, with technicalsupport from Panagiotis Kontaxis, Diploma of Electrical and Computer Engineering.;February 27, 2024;;;;;;Greek;;
Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this sourceLNC-ES-AR_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
Spanish, Argentina Edition;;;Version 2.77;Argentina;Conceptum Medical Terminology Center;February 27, 2024;;;;;;Spanish;;Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-ES-ES_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
Spanish, Spain Edition;;;Version 2.77;Spain;The Clinical Laboratory Committee of SERVICIO EXTREMENO DE SALUD,
with the support of BITAC MAP.;February 27, 2024;;;;;;Spanish;;Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-ES-MX_277 (updated) - ;;The Regenstrief Institute, Inc.;Manuel Aragones;Logical Observation Identifier Names andCodes (LOINC), Spanish, Mexico Edition;;;Version 2.77;Mexico;Deep Dive Data Science;February 27, 2024;;;;;;Spanish;;Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-ET-EE_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
Estonian, Estonia Edition;;;Version 2.77;Estonia;Estonian E-Health Foundation;February 27, 2024;;;;;;Estonian;;
Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-FR-BE_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
French, Belgium Edition;;;Version 2.77;Belgium;Jean M. Prevost, MD, Biopathology;February 27, 2024;;;;;;French;;Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-FR-CA_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
French, Canada Edition;;;Version 2.77;Canada;Canada Health Infoway Inc.;February 27, 2024;;;;;;French;;Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-FR-FR_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
French, France Edition;;;Version 2.77;France;ASIP Sante (Agence des systemes d'information partages de de sante);February
27, 2024;;;;;;French;;

Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-IT-IT_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
Italian, Italy Edition;;;Version 2.77;Italy;Consiglio Nazionale delle Ricerche;February 27, 2024;;;;;;Italian;;
Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-KO-KR_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
Korean, Korea Edition;;;Version 2.77;Republic of Korea;Korean Ministry for Health, Welfare, and Family Affairs;February
27, 2024;;;;;;Korean;;Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-NL-NL_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
Dutch, Netherlands Edition;;;Version 2.77;Netherlands;NVKC, Dutch Society for Clinical Chemistry and Laboratory
Medicine, The Netherlands;February 27, 2024;;;;;;Dutch;;Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-PL-PL_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
Polish, Poland Edition;;;Version 2.77;Poland;Polish Society of Laboratory Diagnostics;February 27, 2024;;;;;;Polish;;Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-PT-BR_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
Portuguese, Brazil Edition;;;Version 2.77;Brazil;HL7 Brazil Institute;February 27, 2024;;;;;;Portuguese;;
Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-RU-RU_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
Russian, Russia Edition;;;Version 2.77;Russia;Yaroslavl State Medical Academy;February 27, 2024;;;;;;Russian;;
Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;Read more information about this source
LNC-TR-TR_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
Turkish, Turkey Edition;;;Version 2.77;Turkey;LOINC Turkish Translation Group and the Turkish Ministry of
Health;February 27, 2024;;;;;;Turkish;;Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-UK-UA_277 (updated) - ;;The Regenstrief Institute, Inc.;;Logical Observation Identifier Names and Codes (LOINC),
Ukrainian, Ukraine Edition;;;Version 2.77;;Valentyna Lemish MD and Oleksandr Kyzoviy (TerraLab IT, LLC) in cooperation
with CO "100% LIFE" and Strimco LLC;February 27, 2024;;;;;;Ukrainian;;
Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
LNC-ZH-CN_277 (updated) - ;;The Regenstrief Institute, Inc., Inc.;;Logical Observation Identifier Names and Codes(LOINC), Chinese, China Edition;;;Version 2.77;China;Lin Zhang, a LOINC volunteer from China;February 27,2024;;;;;;Chinese;;
Contact: LOINC c/o Regenstrief Institute;;The Regenstrief Institute, Inc;1101 West 10th Street, Indianapolis, IN
46202;;Indianapolis;IN;United States;46202;(317) 277-9000;; loinc@loinc.org ;https://loinc.org/;
Read more information about this source
MCM92 - ;;;;Glossary of Methodologic Terms for Clinical Epidemiologic Studies of Human Disorders;;;;Canada;McMaster
University;1992;;;;;;;;
Contact: R. Brian Haynes, M.D., Ph.D.;; Clinical Epidemiology & Biostatistics and Medicine, Faculty of Health Sciences,
McMaster University;1200 Main Street;Room 2C10B;West Hamilton;Ontario ;Canada ;L8N 3Z5;(905) 525-9140;;bhaynes@mcmaster.ca ;Read more information about this source
MDR26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA);;;Version 26.1;;MedDRAMSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;12975 Worldgate Drive;;Herndon;VA;United States;20170-6008;1-571-508-1491;;
mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRARA26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Arabic
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRBPO26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Brazilian Portuguese
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRCZE26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Czech
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRDUT26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Dutch
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDREST26_1 (new) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Estonian Edition;;;Version
26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRFIN26_1 (new) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Finnish Edition;;;Version
26.1;;MedDRA MSSO;;December 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this sourceMDRFRE26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), French
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRGER26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), German
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRGRE26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Greek
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRHUN26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Hungarian
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRITA26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Italian
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRJPN26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Japanese
Edition;;;Version 26.1, Japanese Edition;;MedDRA MSSO;;September 2023;;;;;;;

CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA Japanese Maintenance Organization (JMO);Nagai Kinenkan 3F;2-12-15 Shibuya, Shibuyaku;Tokyo;;Japan;150-0002;+81-3-3400-5608;+81-3-3400-5609; info.jmo@pmrj.jp ; http://www.pmrj.jp/jmo/php/indexe.php ;Read more information about this source
MDRKOR26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Korean
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRLAV26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Latvian
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRPOL26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Polish
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRPOR26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Portuguese
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRRUS26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Russian
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;Read more information about this source
MDRSPA26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Spanish
Edition;;;Version 26.1, Spanish Edition;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MDRSWE26_1 (updated) - ;;;;Medical Dictionary for Regulatory Activities Terminology (MedDRA), Swedish
Edition;;;Version 26.1;;MedDRA MSSO;;September 2023;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;MedDRA MSSO;7575 Colshire Drive;;McLean;Virginia;United States;22102;1-877-258-8280(Toll freeinternational),1-703-556-2950(Direct);1-703-556-1744; mssohelp@meddra.org ;https://www.meddra.org/;
Read more information about this source
MEDCIN3_2023_12_19 (updated) - ;;Medicomp Systems;;MEDCIN;;;;Chantilly, VA;Medicomp Systems;;December 19,
2023;Chantilly, VA;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: David Lareau;Chief Executive Officer;Medicomp Systems;14500 Avion Parkway, Suite 175;;Chantilly;VA;UnitedStates;20151;703-803-8080;703-803-8235; info@medicomp.com ;https://www.medicomp.com;
Read more information about this source
MEDLINEPLUS_20231101 (updated) - ;;;;MedlinePlus Health Topics;;;;;National Library of Medicine;;November 1,
2023;Bethesda, MD;;;;;;
Contact: ;;National Library of Medicine;8600 Rockville Pike;Bldg.38;Bethesda;MD;United States;20894;(888) 346-3656;(301) 402-1384; custserv@nlm.nih.gov ;https://www.nlm.nih.gov/medlineplus/xml.html;
Read more information about this source
MEDLINEPLUS_SPA_20231101 (updated) - ;;;;MedlinePlus Spanish Health Topics;;;;;National Library ofMedicine;;November 1, 2023;Bethesda, MD;;;;;;
Contact: ;;National Library of Medicine;8600 Rockville Pike;Bldg.38;Bethesda;MD;United States;20894;(888) 346-3656;(301) 402-1384;;https://www.nlm.nih.gov/medlineplus/xml.html;
Read more information about this source
MED-RT_2024_03_04 (updated) - ;;;;Medication Reference Terminology (MED-RT);;;;;U.S. Department of Veterans
Affairs, Veterans Health Administration;;March 4, 2024;;;;;;;
Contact: John Kilbourne;Physician, Clinical Information and Terminology;Veterans Health Administration, Knowledge BasedSystems (KBS);Clinical Informatics and Data Management Office (CIDMO);10A7, VHA;;;United States;;;;John.Kilbourne@va.gov ;;Read more information about this source
MMSL_2024_02_01 (updated) - ;;;;Medisource Lexicon;;;February 01, 2024;Denver, CO;Multum Information Services,
Inc.;;;;;;;;;CATEGORY 1 RESTRICTIONS APPLYContact: ;;Multum Information Services;3200 Cherry Creek South Drive, Suite 300;;Denver;CO;United States;80209;888-6334772 x1420;;; http://www.multum.com/
Read more information about this source
MMX_2024_02_05 (updated) - ;;;;Micromedex RED BOOK;;;February 05, 2024;;;;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;Micromedex;6200 South Syracuse Way, Suite 300;;Englewood;CO;United States;80111-4740;(800) 525-9083;;
info@mdx.com ;https://www.ibm.com/us-en/marketplace/micromedex-with-watson/
Read more information about this source
MSH2024_2024_02_01 (updated) - ;;;;Medical Subject Headings (MeSH);;;2024;;U.S. National Library ofMedicine;;February 1, 2024;Bethesda, MD;;;;;;
This source has been translated into many languages. To date, eight of the translations have been incorporated into the UMLS
Metathesaurus.
Contact: ;;National Library of Medicine;8600 Rockville Pike;;Bethesda;MD;United States;20894;(888) FINDNLM;;;https://www.nlm.nih.gov/mesh;
Read more information about this source
MSH2015_2014_09_08 - ;;;;Medical Subject Headings (MeSH);;;2015;;U.S. National Library of Medicine;2015;;Bethesda,
MD;;;;;;;;
This source has been translated into many languages. To date, eight of the translations have been incorporated into the UMLS
Metathesaurus.
Contact: John Kilbourne, M.D.;Head, MeSH Section;National Library of Medicine;6701 Democracy Boulevard,;Suite
202;Bethesda;MD;United States;20894;(301)-496-1495;(301)-402-2002; kilbourj@mail.nih.gov ;http://www.nlm.nih.gov/mesh ;Read more information about this source
MSHCZE2024 (updated) - ;;Dept. of Bibliography, National Library of Medicine;;Czech translation of the Medical Subject
Headings;;;;Prague, Czech Republic;;;2024;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Marie Votipkova;;Dept. of Bibliography, National Library of Medicine;Sokolska 54;;Prague;;Czech Republic;;;;votipkov@nlk.cz ;https://www.nlk.cz;

Read more information about this source
MSHDUT2005 - ;;;;Nederlandse vertaling van MeSH [Dutch translation of MeSH);;;;;Nederlands Tijdschrift voor
Geneeskunde [Dutch Journal of Medicine];;2005;Amsterdam, The Netherlands;;;;DUT;;
CATEGORY 3 RESTRICTIONS APPLYContact: A.J.P.M.Overbeke;;;;;;;;;(20)-662-0150;; overbeke@ntvg.nl ;Read more information about this source
MSHFIN2008 - ;;;;Finnish Translations of Medical Subject Headings (MeSH);;;;Finnish Medical Society
Duodecim;;;2008;Helsinki, Finland;;;;FIN;;
CATEGORY 3 RESTRICTIONS APPLYContact: Dr. Peter Nyberg;;Finnish Medical Network;Fennomed Oy;Makelankatu 2 A;Helsinki;Puh;Finland;00500;(09)-393091;(09)-3930-807; peter.nyberg@sll.fimnet.fi ; http://www.fimnet.fi
Read more information about this source
MSHFRE2024 (updated) - ;;;;Thesaurus Biomedical Francais/Anglais [French translation of the Medical Subject
Headings];;;2024;;Institut National de la Sante et Recherche Medicale;;;Paris, France;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Sylvie Lemercier;;Inserm, Departement Information Scientifique et Communication;Immeuble Kadence;86 rue
Regnault;Paris;;France;75013;;; sylvie.lemercier@inserm.fr ;https://www.inserm.fr/;
Read more information about this source
MSHGER2023 - ;;;;German translation of Medical Subject Headings (MeSH);;;;Cologne, Germany;ZB MED - Information
Centre for Life Sciences;;2023;;;;;;;
Contact: Dietrich Rebholz;;ZB MED - Information Centre for Life Sciences;Gleueler Strasse 60;;Koln;;Germany;50931;(49)-221-478-71 00;; rebholz@zbmed.de ;https://www.zbmed.de/;
Read more information about this source
MSHITA2019 - ;;;;Italian translation of Medical Subject Headings;;;;Rome, Italy;Istituto Superiore di Sanita, Settore
Documentazione;;2019;Rome(Italy);;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Dr. Maurella Della Seta;Direttore;Istituto Superiore di Sanita;229 Viale Regina Elena;;Rome;;Italy;00161;39-0649903277;39-06-49387117; maurella.dellaseta@iss.it ; http://www.iss.it ;Read more information about this source
MSHJPN2014 - Igaku-Chuo-Zasshi.;;NPO Japan Medical Abstracts Society (JAMAS);;JAMAS Japanese Medical Thesaurus(JJMT);;;;Tokyo, Japan;;;2015;;;;;Japanese;;CATEGORY 3 RESTRICTIONS APPLYContact: Yosuke Seyama;;Japan Medical Abstracts Society;2-5-18, Takaido-Higashi, Suginami-ku;;;Tokyo;Japan;168-0072;;;
seyama@jamas.or.jp ;Read more information about this source
MSHLAV2012 - ;;;;Latvian translation of the Medical Subject Headings;;;;;Medical Library of Latvia;;2012;Riga (Latvia);;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Velta Poznaka;Director;Medical Library of Latvia;;;;;;;+371 67373646;+371 67373642; Velta.Poznaka@lmb.gov.lv ;Read more information about this source
MSHNOR2019 - Sigrun Espelien Aasen;;;;Norwegian translation of the Medical Subject Headings (MeSH);;;;Oslo,
Norway;;;2019;Oslo, Norway;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Sigrun Espelien Aasen;Retired Research librarian/Senior adviser;Division for health services, Norwegian Institute of
Public Health;Hovseterveien 52 B;N-0768;Oslo;;Norway;;+47 976 70 819;; sigrunespelien@gmail.com ;;Read more information about this source
MSHPOL2024 (updated) - ;;;;Polish Translation of the Medical Subject Headings;;;2024;;Central Medical Library;;;Warsaw,
Poland;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Dorota Ubysz;;Central Medical Library;Department of Medical Information Center;22, Chocimska Str. 00791;Warsaw;;Poland;;+48 22 849 78 51;; d.ubysz@gbl.waw.pl ; http://www.gbl.waw.pl ;Read more information about this source
MSHPOR2024 (updated) - ;;BIREME/PAHO/WHO;;Descritores em Ciencias da Saude [Portuguese translation of Medical
Subject Headings];;;;;Centro Latino-Americano e do Caribe de Informacao em Ciencias da Saude;;2024;Sao Paulo (Brasil);;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Dr. Ana Cristina Espindola Campos;;TCS AFI BIREME PAHO WHO;Centro Latinoamericano y del Caribe deInformacion en Ciencias de la Salud;Rua Vergueiro, 1759 - 12. andar;Sao Paulo;SP;Brasil;04101-000;;; camposan@paho.org;;
Read more information about this source
MSHRUS2024 (updated) - ;;;;Russian Translation of the Medical Subject Headings;;;2024;;State Central Scientific Medical
Library;;;Moscow, Russia;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Vladimir V'yugin;;The State Central Scientific Medical Library;30, Krasikova St.;;Moscow;;Russia;117418;;;
vyugin2@mail.ru ;;Read more information about this source
MSHSCR2019 - ;;;;Croatian translation of the Medical Subject Headings (MeSH);;;;Zagreb, Croatia;University of Zagreb
School of Medicine - Central Medical Library;;2019;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Lea Skoric;;University of Zagreb School of Medicine - Central Medical Library;Salata
3;;Zagreb;;Croatia;10000;+385-1-4566936;; lea.skoric@mef.hr ; http://smk.mef.unizg.hr/ ;Read more information about this source
MSHSPA2024 (updated) - ;;BIREME/PAHO/WHO;;Descritores en Ciencias de la Salud [Spanish translation of the Medical
Subject Headings];;;;;Centro Latino-Americano e do Caribe de Informacao em Ciencias da Saude;;2024;Sao Paulo (Brasil);;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Dr. Ana Cristina Espindola Campos;;TCS AFI BIREME PAHO WHO;Centro Latinoamericano y del Caribe deInformacion en Ciencias de la Salud;Rua Vergueiro, 1759 - 12. andar;Sao Paulo;SP;Brasil;04101-000; camposan@paho.org;;;;
Read more information about this source
MSHSWE2021 - ;;;;Swedish Translation of Medical Subject Headings;;;;;Universitetsbiblioteket, Karolinska
Institutet;;2021;Stockholm, Sweden;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;Universitetsbiblioteket, Karolinska Institutet;Fe 200 (Berzelius vag 7B), SE-171 77;;Stockholm;;Sweden;;;;ub@ki.se ;https://kib.ki.se;
Read more information about this source
MTH - ;;;;UMLS Metathesaurus;;;;Bethesda, MD;National Library of Medicine;;;;;;;;;
Concept names with this source abbreviation were created by NLM to facilitate creation of the UMLS Metathesaurus. There
are relatively few of them.
Contact: UMLS Support;;;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
MTHCMSFRF_2020_24_03_04 (updated) - ;;;;Metathesaurus Forms of CMS Formulary Reference File;;;2020;Bethesda,
MD;National Library Of Medicine;;;;;;;;;;;
Contact: RxNorm Customer Service;;U.S. National Library of Medicine;8600 Rockville Pike;;Bethesda;MD;UnitedStates;20894;(888) FIND-NLM;; rxnorminfo@nlm.nih.gov ;https://www.nlm.nih.gov/research/umls/rxnorm/
Read more information about this source
MTHICD9_2014 - ;;;;Metathesaurus additional entry terms for ICD-9-CM [computer file]: International Classification of
Diseases, Ninth Revision, Clinical Modification;;;;National Library of Medicine;;October 1, 2013;;Bethesda, MD;;;;;;

Contact: UMLS Support;;National Library of Medicine;8600 Rockville Pike;;Bethesda;Maryland;United States;20894;;;
custserv@nlm.gov ;Read more information about this source
MTHICPC2EAE_200203 - Henk Lamberts and Inge Hofmans-Okkes;;Classification Committee of the World Organizationof National Colleges, Academies and Academic Associations of General Practitioners/Family Physicians (WONCA), known
more briefly as the World Organization of Family Doctors;;International Classification of Primary Care 2nd Edition,
Electronic, 2E, American English Equivalents;;;;Amsterdam;World Organization of Family Doctors;2002;;;;;;;;CATEGORY 3 RESTRICTIONS APPLY
Concept names with this source abbreviation were created by NLM to provide contextual information for ICPC2E terms.
Contact: Prof. Dr. H.Lamberts and Inge M. Okkes;;Department of Family Practice, Division Clinical Methods & Public
Health, Academic Medical Center/University of Amsterdam;Meibergdreef 15 (Room J2-213), 1105 AZ;;Amsterdam;;The
Netherlands;;31 20 566 4711;;;
Read more information about this source
MTHICPC2ICD10AE_0412 - Henk Lamberts and Inge Hofmans-Okkes;;Classification Committee of the World
Organization of National Colleges, Academies and Academic Associations of General Practitioners/Family Physicians(WONCA), known more briefly as the World Organization of Family Doctors;;International Classification of Primary Care,
American English Equivalents;;;;;World Organization of Family Doctors;2002;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Prof. Dr. H. Lamberts and Inge M. Okkes, PhD;;Department of Family Practice, Division of Clinical Methods &Public Health, Academic Medical Center/University of Amsterdam;Meibergdreef 15 (Room J2-213);1105
AZ;Amsterdam;;The Netherlands;;31 20 566 4711;;;
Read more information about this source
MTHMST2001 - ;;;;Metathesaurus Version of Minimal Standard Terminology Digestive Endoscopy;;;;Bethesda,
MD;National Library of Medicine;2001;;;;;;;;
Contact: UMLS Support;;;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
MTHMSTFRE_2001 - ;;;;Metathesaurus Version of Minimal Standard Terminology Digestive Endoscopy, French
Translation;;;;Bethesda, MD;National Library of Medicine;2001;;;;;;;NOTE: Users must also obtain rights to use the parent
source.;* NOTE: Now a CATEGORY 0.
Contact: UMLS Support;;;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
MTHMSTITA_2001 - ;;;;Metathesaurus Version of Minimal Standard Terminology Digestive Endoscopy, ItalianTranslation;;;;Bethesda, MD;National Library of Medicine;2001;;;;;;;;* NOTE: Now a CATEGORY 0.

Contact: UMLS Support;;;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
MTHSPL_2024_02_24 (updated) - ;;;;Metathesaurus Forms of the FDA Structured Product Labels;;;2024_02_24;Bethesda,
MD;National Library of Medicine;;;;;;;;;
Contact: RxNorm Customer Service;;U.S. National Library of Medicine;8600 Rockville Pike;;Bethesda;MD;UnitedStates;20894;(888) FIND-NLM;; rxnorminfo@nlm.nih.gov ;https://www.nlm.nih.gov/research/umls/rxnorm/
Read more information about this source
MVX2024_02_12 (updated) - ;;National Center for Immunization and Respiratory Diseases;;Manufacturers of
Vaccines;;;;Atlanta, GA;;;February 12, 2024;;;;;;;
Contact: ;;CDC, National Center for Immunization and Respiratory Diseases Immunization Information System Support
Branch - Informatics;1600 Clifton Road;Mailstop: E-62;Atlanta;GA;United States;30333;;; iisinfo@cdc.gov;https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=mvx;
Read more information about this source
NANDA-I_2018-2020 - Sparks Ralph, Sheila, Craft-Rosenberg, Martha, Herdman, T. Heather, Lavin, Mary Ann,
editors.;;;;NANDA International, Inc. Nursing Diagnoses: Definitions and Classification 2018-2020;;;Tenth;Oxford;Wiley
Blackwell;2014;;;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Isabel Rollings;Digital Licensing Manager;John Wiley & Sons Ltd, Rights Department;The Atrium, SouthernGate;;Chichester;;England;P019 8SQ;0044 (0)1243 770646;; nanda@wiley.com ; http://www.nanda.org/nanda-internationaltaxonomy-licensing.html ;Read more information about this source
NCBI2023_11_01 (updated) - ;;;;NCBI Taxonomy;;;;National Institutes of Health, National Library of Medicine, National
Center for Biotechnology Information;;;November 1, 2023;Bethesda, MD;;;;;;
Contact: ;;National Library of Medicine;8600 Rockville Pike;;Bethesda;MD;United States;20894;;; info@ncbi.nlm.nih.gov;https://www.ncbi.nlm.nih.gov/Taxonomy;
Read more information about this source
NCI2023_09D (updated) - ;;National Cancer Institute, National Institutes of Health;;NCI Thesaurus;;;23.09d;;National Cancer
Institute;;September 25, 2023;Bethesda, MD;;;;;;
Subset only.
Contact: Enterprise Vocabulary Services (EVS);;National Cancer Institute;;;;;;;240-276-5541, 1-888-478-4423 (toll free);;
ncicbiit@mail.nih.gov ;https://cbiit.cancer.gov/application-support;
Read more information about this source
NCISEER_1999 - ;;;;NCI Surveillance, Epidemiology, and End Results (SEER) conversions between ICD-9-CM and ICD-10

neoplasm codes;;;;Bethesda, MD;National Cancer Institute;June 1999;;;;;https://seer.cancer.gov/;;Phone: 301-496-8510.;
Contact: ;;National Cancer Institute;;;Bethesda;MD;;;301-496-8510;;;
Read more information about this source
NDDF_2024_02_14 (updated) - ;;;;FDB MedKnowledge (formerly NDDF Plus);;;February 14, 2024;South San Francisco,
CA;First Databank;;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;First Databank Customer Support;701 Gateway Blvd, Suite 600;;South San Francisco;CA;United States;94080;800633-3453;; cs@fdbhealth.com ;Read more information about this source
NEU2023_06_02 - ;;;;NeuroNames, BrainInfo (1991-present);;;;;National Primate Research Center, University ofWashington;;June 2, 2023;;;; http://www.braininfo.org ;;;CATEGORY 3 RESTRICTIONS APPLYContact: Douglas M. Bowden, MD;Professor of Psychiatry and Behavioral Sciences;Department of Psychiatry & Behavioral
Sciences, University of Washington School of Medicine;UW Department of Psychiatry & Behavioral Sciences;1959 NE
Pacific Street;Seattle;WA;United States;98195;;; dmbowden@u.washington.edu ;http://braininfo.rprc.washington.edu/copyright.aspx ;Read more information about this source
NIC7 - ;;;Butcher, H., Bulechek, G., Dochterman, J., & Wagner, C. (Eds.).;Nursing Interventions Classification (NIC) (7thed.);;;7th ed.;St. Louis, MO;Elsevier;2018;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Bonita Allen;Education Solutions Consultant ;Elsevier Special Markets;3251 Riverport Lane;;Maryland
Heights;MO;;63043;;; b.allen.1@elsevier.com ;https://nursing.uiowa.edu/cncce/copyright-licensing;
Read more information about this source
NOC6 - ;;;Moorhead, S., Swanson, E. Johnson, M., & Maas, M. L. (Eds.);Nursing outcomes classification (NOC):
Measurement of health outcomes (6th ed.);;;6th ed.;St. Louis, MO;Elsevier;2018;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Bonita Allen;Education Solutions Consultant ;Elsevier Special Markets;3251 Riverport Lane;;Maryland
Heights;MO;;63043;;; b.allen.1@elsevier.com ;https://nursing.uiowa.edu/cncce/copyright-licensing;
Read more information about this source
NUCCHCPT_23.1 - ;;National Uniform Claim Committee;;National Uniform Claim Committee - Health Care Provider
Taxonomy;;;;;American Medical Association;;July 1, 2023;Chicago, IL;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Nancy Spector;Chair, National Uniform Claim Committee;AMA, Coding and HIT Advocacy;119 Cherry Hill Rd,

Suite 330;;Parsippany;NJ;United States;07054;(973)263-9898 ext 204;; nancy.spector@ama-assn.org;https://www.nucc.org/index.php/code-sets-mainmenu-41/provider-taxonomy-mainmenu-40;
Read more information about this source
OMIM2024_02_12 (updated) - ;;McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore,MD);;Online Mendelian Inheritance in Man (OMIM);;;;Baltimore, MD;McKusick-Nathans Institute of Genetic Medicine,Johns Hopkins University;;February 12, 2024;;;;;;;
Contact: ;;Johns Hopkins University;;;Baltimore;MD;;;;; JHTT-Communications@jhmi.edu;https://www.omim.org/help/copyright;
Read more information about this source
OMS2005 - Martin, Karen S.;;;;The Omaha System: A Key to Practice, Documentation, and Information
Management;;;2nd;Omaha, NE;Health Connections Press;2005;;;;;;;;CATEGORY 1 RESTRICTIONS APPLYContact: Karen S. Martin, RN, MSN, FAAN;Health Care Consultant;Martin Associates;5711 N. 167th Ave.
Circle;;Omaha;Nebraska;United States;68116;1-402-333-1962;; martinks0007@gmail.com ; http://www.omahasystem.org
Read more information about this source
ORPHANET_2023_07 - ;;French Institute of Health and Medical Research (INSERM);;Orphanet Nomenclature;;;;Paris,
France;;;July 2023;;;;;;;CATEGORY 1 RESTRICTIONS APPLYContact: Charlotte Rodwell;;Partnerships, Business Development and Strategic Communications;Inserm US14 Orphanet;Plateforme Maladies Rares, 96 rue Didiot;Paris;;France;75014;+33 (0) 156538150;; data.orphanet@inserm.fr;www.orpha.net, www.orphadata.com;
Read more information about this source
PCDS97 - Ozbolt, Judy Grace;;;;Patient Data Care Set (PCDS);;;Version 4.0; Nashville, TN;;1998;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Judy Ozbolt;;;Vanderbilt School of Nursing 400-C Godchaux Hall;;Nashville;TN;;37240-0008;(615)343-3291;;
judy.ozbolt@mcmail.vanderbilt.edu ;Read more information about this source
PDQ_2018_10_27 - ;;;;Physician Data Query;;;;;National Cancer Institute;;October 27, 2018;;;;;;;
Contact: ;;National Cancer Institute;;;;;;;;;;https://www.cancer.gov/publications/pdq;
Read more information about this source
PNDS_2024 (updated) - ;;AORN;;Perioperative Nursing Data Set;;;;Denver, CO;AORN, Inc.;;January 2024;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Janice Kelly MS, RN-BC;;AORN Syntegrity Inc.;2170 S Parker Rd Suite 400;;Denver;CO;United States;80231;800755-2676;; syntegrityteam@aorn.org ;;Read more information about this source
PPAC98 - ;;;;Pharmacy Practice Activity Classification (PPAC);;;Version 1;Washington (DC);American Pharmaceutical
Association;1998;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Scott Antall;;American Pharmaceutical Association - Academy of Pharmaceutical Research and Science;2215
Constitution Avenue NW;;Washington;DC;;20037-2985;;; ssa@mail.aphanet.org ;Read more information about this source
PSY2004 - ;;American Psychological Association;Lisa A. Gallagher;Thesaurus of psychological index terms;;;10th ed., 30th
anniversary, 1974-2004;Washington, DC;American Psychological Association;2005;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Lisa A. Gallagher;;American Psychological Association;750 First Street, NE;;Washington;DC ;;20002-4242;202336-5726;; LGallagher@apa.org ;Read more information about this source
QMR96 - ;;;;Quick Medical Reference (QMR);;;;San Bruno (CA);First DataBank;1997;;;;;;;;
Contact: ;;Quick Medical Reference, First Databank;1111 Bayhill Drive;;San Bruno;CA;;94066;;;;
Read more information about this source
RAM99 - Dr. Randolph A. Miller;;;;QMR clinically related terms;;;;;;1999;;;;;;;;
Contact: Dr. Randolph A. Miller;Chair;Dept. of Biomedical Informatics, Vanderbilt University;436 Eskind Biomedical
Library;2209 Garland Ave.;Nashville;TN;;37232-8340;;; randolph.a.miller@vanderbilt.edu ;Read more information about this source
RCD99 - ;.;;;Clinical Terms Version 3 (CTV3) (Read Codes) (Q199);;;;;National Health Service National Coding andClassification Centre; March, 1999;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;NHS Information Authority Loughborough;;Woodgate;Loughborough;Leicestershire ;;LE11 2TG;+44 (0) 1509
211611;; helpdesk3@nhsccc.exec.nhs.uk ;Read more information about this source
RCDAE_1999 - ;;;;American English equivalent of the Clinical Terms ;;;Version 3 (Q1, 1999);Bethesda (MD);National
Library of Medicine, UMLS project;1999;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;;;;;;;;;;;
Read more information about this source
RCDSA_1999 - ;;;;American English equivalent of synthesized terms from the Clinical Terms ;;;Version 3 (Q1,
1999);Bethesda (MD);National Library of Medicine, UMLS project;1999;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;NHS Information Authority Loughborough;Woodgate;;Loughborough;Leicestershire ;;LE11 2TG;;+44 (0) 1509
211611; helpdesk3@nhsccc.exec.nhs.uk ;Read more information about this source
RCDSY_1999 - ;;;;Synthesized Read terms (without initial bracketed letters) of the Clinical Terms;;;Version 3 (Q1,
1999);Bethesda (MD);National Library of Medicine, UMLS project;1999;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: ;;NHS Information Authority Loughborough;Woodgate;;Loughborough;Leicestershire ;;LE11 2TG;;+44 (0) 1509
211611; helpdesk3@nhsccc.exec.nhs.uk ;Read more information about this source
RXNORM_20AA_240304F (updated) - ;;;;RxNorm;;;META2020AA Full Update 2024_03_04;Bethesda, MD;National
Library of Medicine;;;;;;;;;
This release contains concepts created by the National Library of Medicine which express the meaning of a drug name in anormalized form. These concepts relate the names of orderable medications to a dose form and the components of those
medications. For further discussion, see the article at:
http://umlsinfo.nlm.nih.gov/RxNorm.html
Contact: RxNorm Customer Service;;U.S. National Library of Medicine;8600 Rockville Pike;;Bethesda;MD;UnitedStates;20894;(888) FIND-NLM;; rxnorminfo@nlm.nih.gov ;https://www.nlm.nih.gov/research/umls/rxnorm/
Read more information about this source
SCTSPA_2023_09_30 (updated) - ;;SNOMED International;;SNOMED CT Spanish Edition;;;Spanish Language
Edition;London, United Kingdom;;;September 30, 2023;;;;;;;TERMS IN APPENDIX 2 OF UMLS LICENSE APPLY.
"This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International HealthTerminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by
The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO."
Contact: UMLS Support, National Library of Medicine; e-mail: NLM SNOMED CT Support
NLM is a Charter Member of the IHTSDO on behalf of the U.S.
Contact: ;NLM is a Charter Member of SNOMED International on behalf of the U.S.;National Library of Medicine;8600
Rockville Pike;;Bethesda;MD;United States;20894;1-888-FIND-NLM (1-888-3463656);;https://support.nlm.nih.gov/support/create-case/;;Read more information about this source
SNM2 - ;;;Cote, Roger A.;Systematized Nomenclature of Medicine;;;2nd ed.;Skokie (IL);College of American
Pathologists;1982;;;;;;;;TERMS IN APPENDIX 2 OF UMLS LICENSE APPLY.
"This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International HealthTerminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by
The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO."
Contact: UMLS Support, National Library of Medicine; e-mail: NLM SNOMED CT Support
NLM is a Charter Member of the IHTSDO on behalf of the U.S.
Contact: Jill Rosenthal/Naomi Siebert;;College of American Pathologists;325 Waukegan Road;;Northfield;IL;;60093-2750;;(847)832-8335; jnrs@cap.org ;Read more information about this source
SNMI98 - Cote, Roger A.;;College of American Pathologists;;Systematized Nomenclature of Human and Veterinary
Medicine: SNOMED International;;;Version 3.5;Schaumburg (IL);American Veterinary Medical Association;1998;;;;;;;;TERMS IN APPENDIX 2 OF UMLS LICENSE APPLY.
"This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International HealthTerminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by
The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO."
Contact: UMLS Support, National Library of Medicine; e-mail: NLM SNOMED CT Support
NLM is a Charter Member of the IHTSDO on behalf of the U.S.
Contact: Jill Rosenthal/Naomi Siebert;;College of American Pathologists;325 Waukegan Road;;Northfield;IL;;60093-2750;;(847)832-8335; jnrs@cap.org ;Read more information about this source
SNOMEDCT_US_2024_03_01 (updated) - ;;SNOMED International;;US Edition of SNOMED CT;;;;London, United
Kingdom;SNOMED International;;March 1, 2024;;;;;;;TERMS IN APPENDIX 2 OF UMLS LICENSE APPLY.
"This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International HealthTerminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by
The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO."
Contact: UMLS Support, National Library of Medicine; e-mail: NLM SNOMED CT Support
NLM is a Charter Member of the IHTSDO on behalf of the U.S.
Contact: NLM Customer service;NLM is a Charter Member of SNOMED International on behalf of the U.S.;National Libraryof Medicine;8600 Rockville Pike;;Bethesda;MD;United States;20894;1-888-FIND-NLM (1-888-3463656);;https://support.nlm.nih.gov/support/create-case/;;Read more information about this sourceSNOMEDCT_US_2023_09_01 - ;;SNOMED International;;US Edition of SNOMED CT;;;;London, United
Kingdom;SNOMED International;;September 1, 2023;;;;;;;TERMS IN APPENDIX 2 OF UMLS LICENSE APPLY.
"This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International HealthTerminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by
The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO."
Contact: UMLS Support, National Library of Medicine; e-mail: NLM SNOMED CT Support
NLM is a Charter Member of the IHTSDO on behalf of the U.S.
Contact: NLM Customer service;NLM is a Charter Member of SNOMED International on behalf of the U.S.;National Libraryof Medicine;8600 Rockville Pike;;Bethesda;MD;United States;20894;1-888-FIND-NLM (1-888-3463656);;https://support.nlm.nih.gov/support/create-case/;;Read more information about this source
SNOMEDCT_VET_2023_10_01 (updated) - ;;Veterinary Terminology Services Laboratory (VTSL), Virginia Maryland
Regional College of Veterinary Medicine;;Veterinary Extension to SNOMED CT;;;;Blacksburg, VA;Veterinary Terminology
Services Laboratory (VTSL);;October 2023;;;;https://vtsl.vetmed.vt.edu/;;;TERMS IN APPENDIX 2 OF UMLS LICENSE APPLY.
"This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International HealthTerminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by
The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO."
Contact: UMLS Support, National Library of Medicine; e-mail: NLM SNOMED CT Support
NLM is a Charter Member of the IHTSDO on behalf of the U.S.
Contact: ;NLM is a Charter Member of the SNOMED International on behalf of the U.S.;National Library of Medicine;8600
Rockville Pike;;Bethesda;MD;United States;20894;(888)FIND-NLM;;https://support.nlm.nih.gov/support/create-case/;;Read more information about this source
SOP9.2 - ;;National Association of Health Data Organizations (NAHDO);;Source of Payment Typology;;;Version
9.2;;National Association of Health Data Organizations (NAHDO);;December, 2020;;;;;;;
Contact: Barbara Rudolph;;National Association of Health Data Organizations (NAHDO);;;;;;;;; Barbara.Rudolph@wisc.edu;https://www.nahdo.org/node/1043;
Read more information about this source
SPN2003 - ;;;;Standard Product Nomenclature (SPN);;;;Rockville, (MD); U.S. Food and Drug Administration;2003;;;;;;;;
Contact: ;;;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
SRC - ;;;;UMLS Metathesaurus Source Terminologies;;;;Bethesda, MD;National Library of Medicine;;;;;;;;;

Contact: UMLS Support;;;;;;;;;;; custserv@nlm.nih.gov ;Read more information about this source
TKMT2011 - ;;;;Traditional Korean Medical Terms;;;;;;;2011;Korea;;;;KOR;;
Contact: Jinhyun Kim;Researcher/O.M.D;Information Research Center, TKM Information Research Division, Korea Instituteof Oriental Medicine;483 Expo-ro, Yuseong-gu;;Daejeon;;Korea;305-811;+82-42-868-9565, +82-10-2237-2378;+82-42-8619421; kjh970203@kiom.re.kr ;Read more information about this source
ULT93 - Bell, Douglas;;;;Ultrasound Structured Attribute Reporting (UltraSTAR);;;;Boston (MA);Brigham & Womens
Hospital;1993;;;;;;;;CATEGORY 3 RESTRICTIONS APPLYContact: Robert Greenes, M.D., Ph.D.;;Brigham & Womens Hospital;Department of Radiology;75 Francis Street;Boston;MA;;02115;(617) 732-6281;; greenes@harvard.edu ;Read more information about this source
UMD2023 - ;;ECRI Institute;;Universal Medical Device Nomenclature System;;;2023;Plymouth Meeting, PA;;;;;;;;;;CATEGORY 1 RESTRICTIONS APPLYContact: Christina Minner;Manager, UMDNS;ECRI;5200 Butler Pike;;Plymouth Meeting;Pennsylvania;United States;194621298;;; umdns@ecri.org ;https://www.ecri.org/solutions/umdns;
Read more information about this source
USP_2024_01_08_24_03_04 (updated) - ;;;;USP Compendial Nomenclature;;;January, 2024;;United States
Pharmacopeia;January, 2024;;;;;;;;
Contact: Jeffrey Shick; Director Translational Informatics;United States Pharmacopeia;12601 Twinbrook
Parkway;;Rockville;MD;US;20852-1790;1-800-227-8772;; HealthcareQuality@usp.org ; http://www.usp.org/health-qualitysafety
Read more information about this source
USPMG_2023 (updated) - ;;;;USP Medicare Model Guidelines;;;Version 9;;United States Pharmacopeia;September 29,2023;;;;;;;;
Contact: ;;United States Pharmacopeia;12601 Twinbrook Parkway;;Rockville;MD;US;20852-1790;1-800-227-8772;;
ModelGuidelines@usp.org ;https://www.usp.org/health-quality-safety/usp-medicare-model-guidelines;
Read more information about this source
UWDA173 - Jose Mejino, M.D.;;;;University of Washington Digital Anatomist, (UWDA);;;Version 1.7.3;Seattle(WA);University of Washington;March, 2003;;;;;;;;
Contact: Jose Mejino, M.D.;;University of Washington Digital Anatomist Symbolic Knowledge Base, University ofWashington Digital Anatomist Information System, Structural Informatics Group;Department of BiologicalStructure;;Seattle;WA;;98195;;; onard@biostr.washington.edu ;Read more information about this source
VANDF_2024_01_31 (updated) - ;;;;Veterans Health Administration National Drug File;;;January 31, 2024;Washington,
DC;U.S. Department of Veterans Affairs;;;;;;;;;* NOTE: Now a CATEGORY 0.
Contact: Michael Lincoln, M.D.;;U.S. Department of Veterans Affairs, Veterans HealthAdministration;;;Washington;DC;United States;;;; michael.lincoln@med.va.gov ; http://www.pbm.va.gov/default.aspx
Read more information about this source
WHO97 - ;;;;WHO Adverse Drug Reaction Terminology (WHOART);;;;Uppsala (Sweden);WHO Collaborating Centre forInternational Drug Monitoring;1997;;;;;;;;CATEGORY 2 RESTRICTIONS APPLYThe Metathesaurus includes translations of WHO97 in:French (WHOFRE_1997),
German (WHOGER_1997),
Portuguese (WHOPOR_1997), andSpanish (WHOSPA_1997).
Contact: ;;WHO Collaborating Centre for International Drug Monitoring;Stora Target 3;S-753 20;Uppsala;;Sweden;;;+46-18656080;;
Read more information about this source
WHOFRE_1997 - ;;;;WHO Adverse Drug Reaction Terminology (WHOART). French Translation.;;;;Uppsala(Sweden);WHO Collaborating Centre for International Drug Monitoring;1997;;;;;;;;CATEGORY 2 RESTRICTIONS APPLYContact: ;;WHO Collaborating Centre for International Drug Monitoring;Stora Target 3;S-753 20;Uppsala;;Sweden;;;+46-18656080;;
Read more information about this source
WHOGER_1997 - ;;;;WHO Adverse Drug Reaction Terminology (WHOART). German Translation.;;;;Uppsala(Sweden);WHO Collaborating Centre for International Drug Monitoring;1997;;;;;;;;CATEGORY 2 RESTRICTIONS APPLYContact: ;;WHO Collaborating Centre for International Drug Monitoring;Stora Target 3;S-753 20;Uppsala;;Sweden;;;+46-18656080;;
Read more information about this source
WHOPOR_1997 - ;;;;WHO Adverse Drug Reaction Terminology (WHOART). Portuguese Translation.;;;;Uppsala(Sweden);WHO Collaborating Centre for International Drug Monitoring;1997;;;;;;;;

CATEGORY 2 RESTRICTIONS APPLYContact: ;;WHO Collaborating Centre for International Drug Monitoring;Stora Target 3;S-753 20;Uppsala;;Sweden;;;+46-18656080;;
Read more information about this source
WHOSPA_1997 - ;;;;WHO Adverse Drug Reaction Terminology (WHOART). Spanish Translation.;;;;Uppsala(Sweden);WHO Collaborating Centre for International Drug Monitoring;1997;;;;;;;;CATEGORY 2 RESTRICTIONS APPLYContact: ;;WHO Collaborating Centre for International Drug Monitoring;Stora Target 3;S-753 20;Uppsala;;Sweden;;;+46-18656080;;
Read more information about this source

APPENDIX 2
SNOMED CT® AFFILIATE LICENSE AGREEMENTIMPORTANT NOTICE – PLEASE READ THE FOLLOWING CAREFULLYThis is a License Agreement between (1) The International Health Terminology Standards Development Organisation,(trading as SNOMED International) , a private company limited by guarantee and established under the laws of England(registered number 09915820), with its registered office at One Kingdom Street, Paddington Central, London, W2 6BD (the" Licensor "), and (2) the person or organization to which the International Release of SNOMED CT (whether on its own oras part of a Member's National Release of SNOMED CT) is distributed or otherwise made available (the " Licensee ").
By downloading, accessing or using any part of the International Release of SNOMED CT or a Member's National Releaseof SNOMED CT, or exercising any rights granted under this License Agreement, the Licensee agrees to be bound by theterms of this License Agreement.
License Fees and other conditions and restrictions apply to the use of the International Release of SNOMED CT in a NonMember Territory, and to the deployment, distribution and licensing of Licensee Products within a Non-Member Territory.
In this regard the Licensee's attention is drawn in particular to clause 7 (License Fees) and clause 9 (Use in Member
Territories and Non-Member Territories) .
1. DEFINED TERMS AND INTERPRETATION
1.1 In this License Agreement, terms defined in Appendix A ( Defined Terms ) have the meanings set out in that Appendix.
1.2 In the event of any conflict or inconsistency between the English language version and any other language version of thisLicense Agreement, the English language version shall take precedence.
2. GRANT OF LICENSE
2.1 The Licensor grants the Licensee, subject to the terms of this License Agreement, a perpetual (subject to revocation inaccordance with clause 5 ), worldwide, non- exclusive, non-transferable license for the term of this License Agreement to:
2.1.1

use, and permit the Licensee's officers, employees, agents and contractors to use, the International Release;

2.1.2 create Extensions and Derivatives from the International Release and use and modify those Extensions andDerivatives;
2.1.3 incorporate the International Release into Licensee Products, and distribute Licensee Products under a sublicense in accordance with clause 2.1.5 ;
2.1.4 modify the manner of formatting of the copy of the SNOMED CT Core distributed to the Licensee as partof the International Release or as part of a Member's National Release; and2.1.5 subject to clause 5.8 , grant sub-licenses of the International Release to End Users to the extent necessary
for the End Users to use the Licensee Products.
2.2 The Licensee may only use the International Release, and must ensure that its officers, employees, agents and contractors
only use the International Release:
2.2.1 for the Licensee's internal business purposes (including the creation by the Licensee of Extensions,
Derivatives and other Licensee Products along with the licensing and distribution by the Licensee of the Licensee
Products);
2.2.2 in the development and operation of the Licensee's information systems;
2.2.3

for the Licensee's research purposes;

2.2.4 in the Licensee's systems (including browsers and data analysis systems) made available to the generalpublic for accessing and/or retrieving any part of the International Release and/or data encoded using theforegoing, provided that users of those systems are not able to extract any substantial portion of SNOMED CT andprovided further that no fee is charged for access to those systems except where access is incidental to theprovision of training or consulting services; and/or
2.2.5 to transmit to third parties messages that contain patient information encoded using SNOMED CT,
provided that the SNOMED CT Content contained within those messages consists solely of SNOMED CT
Identifiers and descriptions of SNOMED CT concepts.
2.3 The Licensee is only permitted under this License Agreement to create Extensions from the International Release and tocreate Derivatives from the International Release and from those Extensions. The Licensee may only create an Extension or a
Derivative from any Member's Extension pursuant to a license agreement with that Member in respect of the Member's
National Release.
2.4 The Licensee is not permitted to translate any part of the International Release into any other human language without theprior written consent of the Licensor.
2.5 Each sub-license granted by the Licensee under clause 2.1.5 must:
2.5.1 not grant the End User any greater rights in respect of the International Release than the Licensee itself has
under this License Agreement;
2.5.2 not permit the End User to do any act or thing in respect of the International Release that the Licensee isprohibited from doing under this License Agreement;
2.5.3 not permit the End User to sub-license or transfer any of its rights under the sub-license (unless the End
User is also an Affiliate, in which case that Affiliate shall be entitled to sub-license further its rights under the sublicense with the Licensee, subject to the same restrictions as apply to sub- licensing the International Release
under the Affiliate's license agreement with the Licensor);
2.5.4

terminate automatically upon termination of this License Agreement;

2.5.5 provide that the End User may apply directly to the Licensor upon receiving notice that the sub-license willterminate in accordance with clause 2.5.4,
and that the Licensor may in such circumstances (but shall not be obliged to):(a) grant the End User a license in respect of the International Release for a limited period in orderto enable the End User to continue to use the Licensee Products that are subject to the sub-licenseduring that period; or(b) give the End User an assurance or undertaking that for a limited period the Licensor will notseek to prevent the End User from using the Licensee Products; and2.5.6 permit the Licensee to disclose the terms of the sub-license to the Licensor in accordance with clauses 7 and
8.
2.6 If the Licensee becomes aware of any material error or change or correction needed in the International Release, theLicensee agrees to advise the Licensor promptly of such error, change or correction by following the Licensor's procedures forchange notification that the Licensor prescribes by Regulations and notifies to the Licensee from time to time.
2.7 The Licensee shall implement reasonable measures to ensure that the International Release (and any part of it) cannot be
accessed or downloaded from the Licensee’s systems except by authorised users, and shall comply with the security measuresthat the Licensor prescribes by Regulations and notifies to the Licensee from time to time.
3. EXTENSIONS AND DERIVATIVES
3.1 The Licensee may not create any Standards-Based Extension or any Standards Based Derivative unless it has first been
issued with a Namespace Identifier by or on behalf of the Licensor.
3.2 The Licensee may request that the Licensor issue it with a Namespace Identifier, and the Licensor shall not unreasonably
refuse to do so taking into account amongst other things quality assurance, governance processes, Standards and Regulations.
3.3 The Licensee shall ensure that all Standards-Based Extensions and Standards Based Derivatives that the Licensee creates
under this License Agreement are created in accordance with, and comply with, all applicable Standards (including, without
limitation, as to the use of Namespace Identifiers).
3.4 Subject to clauses 3.5 and 3.6 , the Licensee shall own all Intellectual Property Rights in all Extensions and Derivatives
that the Licensee creates under this License Agreement. The Licensee may not assign or otherwise transfer those Intellectual
Property Rights to any other person unless (i) that person is an Affiliate and, in the case of Standards-Based Extensions orStandards-Based Derivatives, has a Namespace Identifier; and (ii) the transfer is notified in writing to the Licensor within
thirty (30) days after the transfer.
3.5 The Licensee shall, if requested by the Licensor, transfer to the Licensor or a Member nominated by the Licensor all of its
Intellectual Property Rights in such Standards-Based Extensions (or parts thereof) as the Licensor may specify.
3.6 The parties may agree from time to time that the Licensee shall transfer to the Licensor (or a Member nominated by the
Licensor), the Licensee's Intellectual Property Rights in one or more Standards-Based Derivatives.
3.7 Upon the transfer to the Licensor, or to a Member, of the Intellectual Property Rights in one or more Standards-Based
Extension (or part thereof) or Standards-Based Derivatives in accordance with clauses 3.5 or 3.6 :3.7.1 responsibility for the maintenance and distribution of that Extension (or part thereof) or Derivative shallalso transfer from the Licensee to the Licensor or the Member (as the case may be); and3.7.2 the Licensor hereby grants a license back to the Licensee from the Licensor or will procure from theMember a license back to the Licensee (as the case may be) of that Extension (or part thereof) or Derivative, on
the same terms as apply to the International Release under clause 2 of this License Agreement, until that
Extension (or part thereof) or Derivative becomes part of the International Release or the Member's National
Release (as the case may be).
4. MODIFICATIONS TO THE INTERNATIONAL RELEASE
4.1 Subject to clause 2.1.4 , the Licensee may not modify any part of the SNOMED CT Core distributed as part of theInternational Release or as part of a Member's National Release.

4.2 Subject to any express and specific statement to the contrary in the documentation distributed as part of the International
Release, the Licensee may not modify any of the documentation (including Specifications) or software (unless provided insource code form) distributed as part of the International Release.
4.3 The Licensee may, by written notice, request the Licensor to modify the SNOMED CT Core. Upon receipt of such written
notice, the Licensor shall consult with the Licensee and shall give due consideration as to whether the proposed modification
should be made based on the Licensor's editorial guidelines and policies. Following due consideration of the matter, including
consideration of any information presented by the Licensee, the Licensor shall inform the Licensee whether the proposed
modification shall be made and if the Licensor agrees that the proposed modification should be made, the Licensor shall give a
non-binding indication of when, reasonably and in good faith, it anticipates that the proposed modification will be made. If theLicensee would like the content of the proposed modification to be developed more quickly than the Licensor has indicated,the Licensee may itself undertake or procure the undertaking of the development of the content of the proposed modification(outside of any existing Licensor's support services contract). On receipt of the developed content of the proposed
modification, the Licensor will then give due consideration as to whether the developed content meets the Licensor's quality
assurance, other governance processes, Standards and Regulations. If the developed content meets the Licensor's quality
assurance, other governance processes, Standards and Regulations then the Licensor shall incorporate the modification into the
SNOMED CT Core according to its schedule which will give due consideration as to when the proposed modification shall beincorporated into the SNOMED CT Core, taking into account other proposals for the modification of the SNOMED CT Coreand the work required to include the proposed modification in the SNOMED CT Core.
5. TERM AND TERMINATION
5.1 This License Agreement shall commence on the date on which it comes into effect in accordance with the notice at the
beginning of this License Agreement, and shall continue until terminated in accordance with this clause 5 .
5.2 Either party may terminate this License Agreement if the other party commits a material breach of any of its obligations
under this License Agreement (which, in the case of the Licensee, shall include, without limitation, any failure to pay License
Fees when due under clause 7 ) in accordance with the following procedure:
5.2.1 the party seeking to terminate the License Agreement (the " Terminating Party ") shall serve an
escalation notice (the " Escalation Notice ") on the other party (the " Defaulting Party ") requiring the Defaulting
Party to nominate a member of its senior management team to meet with a member of the Terminating Party's
senior management team to seek to resolve in good faith the matter giving rise to the service of the escalation
notice.
5.2.2 The representatives of the parties identified in accordance with clause 5.2.1 shall meet in good faith to seek
to resolve the matter. If they are unable to resolve the matter within 45 days of the date of the Escalation Notice
the Terminating Party may serve a formal breach notice (the " Breach Notice ") on the Defaulting Party requiring
it to remedy the breach within 90 days.
5.2.3 If the Defaulting Party does not remedy the breach within 90 days of the date of the Breach Notice theTerminating Party may terminate the License Agreement by giving 180 days' written notice to the Defaulting
Party (the " Termination Notice ").
5.3 Neither party may terminate this License Agreement except in accordance with this clause 5 .
5.4 The Licensee may terminate this License Agreement by giving up to twelve (12) months' prior written notice to the
Licensor.
5.5 Upon termination of this License Agreement in accordance with this clause 5 , all licenses granted under this License
Agreement shall automatically and immediately be revoked, except as provided in clause 5.13.
5.6 The Licensee shall, by no later than forty five (45) days after termination of this License Agreement for any reason, remove
all copies of the International Release from its computer systems and destroy all copies of electronic, paper copy and othermedia containing or representing any part of the International Release, except for any copies of the International Release usedsolely for purposes of the Licensee exercising its rights under clause 5.13. The Licensee shall, if requested by the Licensor,
certify in writing to the Licensor that the Licensee has complied with its obligations under this clause 5.6 .

5.7 The Licensee shall, as soon as reasonably practicable following either party giving a Termination Notice for any reason,and in any event by no later than ninety (90) days after such Termination Notice is given, give written notice of suchtermination to each End User that the Licensee reasonably believes to be a current user of a Licensee Product and to each
Member in each Member Territory in which the Licensee has distributed or licensed any Licensee Product.
5.8 The Licensee may not grant any new sub-license under clause 2.1.5 after either party has given notice under clauses 5.2 or
5.4 .
5.9 The Licensor shall be entitled to publicize the termination of this License Agreement to such persons (including Members,
other Affiliates of the Licensor and End Users) and in such manner as it sees fit.
5.10 Clauses 5.6, 5.7, 5.8, 5.9, 5.11, 5.12, 5.13, 7, 8 and 10 to 14 inclusive shall survive termination of this License
Agreement.
5.11 The Licensee shall, by no later than thirty (30) days after termination of this License Agreement for any reason, submit astatement of account in accordance with clause 7.3 in respect of all periods that have not previously been covered by astatement of account under that clause.
5.12 Any termination of this License Agreement, for any reason, is without prejudice to the accrued liabilities of each party asat the date of termination (including, without limitation, any liability of the Licensee to pay License Fees that has accrued as at
the date of termination), or to the Licensee's obligation to pay License Fees arising from the statement of account submitted
under clause 5.11 .
5.13 The Licensee may, following termination of this License Agreement, continue to use the most recent version of theInternational Release as at the date of termination (such version, the “Final Permitted Version” ), solely for purposes ofreading records created prior to the date of termination and encoded using the Final Permitted Version or a prior version of theInternational Release. The Licensee has no right under this clause 5.13: (a) to create any record encoded using any version of
the International Release; (b) to modify any SNOMED CT Content in any record encoded using any version of theInternational Release; or (c) in respect of any version of the International Release subsequent to the Final Permitted Version.
6. NEW VERSIONS AND CHANGES TO LICENSE TERMS
6.1 The Licensor shall notify the Licensee when each new version of the International Release is made available and there
shall be a mechanism for the Licensee to access or obtain copies of the new version of the International Release. The Licensee
shall be liable for any reasonable distribution charge, if applicable, established by the Licensor for each copy of the newversion of the International Release.
6.2 Within one-hundred and eighty (180) days after the Licensor has notified the Licensee of the release of a new version of
the International Release, the Licensee must upgrade the version of the International Release in its own systems and in the
Licensee Products to that new version (or alternatively, if a subsequent version of the International Release is or has beenreleased during the 180-day period, to that subsequent version at the Licensee's option).
6.3 The Licensor may vary the terms of this License Agreement by giving written notice to the Licensee. Any such variation
shall take effect not less than ninety (90) days after the notice is given, as specified in the notice. If the Licensee does not wish
this License Agreement to continue subject to the variation, the Licensee may terminate this License Agreement in accordancewith clause 5.4 , and if the Licensee gives notice of such termination before the variation takes effect then the variation shallnot apply as between the Licensor and the Licensee.
6.4 The College of American Pathologists, as originator of Intellectual Property Rights in the International Release, shall as alicensee have a specific [exception] to the Licensor's rights in clause 6.3 in specific circumstances and for a specific fixed term
period to be agreed with the Licensor, and the terms of such special [ exemption] shall be deemed part of such licensee's
Affiliate License Terms. The Licensor will publish the terms of the special exemption with the Articles.
7. LICENSE FEES
7.1 The Licensee shall pay the License Fees to the Licensor in respect of the Licensee's activities in Non-Member Territories.
The License Fees shall be payable annually in arrear.

7.2 All License Fees and other amounts payable to the Licensor under this License Agreement are exclusive of value added tax
and any other tax of a similar nature, which shall be payable by the Licensee at the prevailing rate in addition to those amounts.
7.3 The Licensee shall, at least once in each calendar year, submit a statement of account to the Licensor in such manner andform as the Licensor may prescribe from time to time, setting out the Licensee's activities in Non-Member Territories since theend of the period covered by the previous statement of account submitted under this clause 7.3 (or, in the case of the firststatement of account under this clause 7.3 , since the date on which this License Agreement became effective), and theLicensee's calculation of the License Fees and other amounts payable to the Licensor in respect of that period. Each suchstatement of account shall include, without limitation, a list of all license agreements in respect of Licensee Products that werein force during the period covered by the statement of account and, in relation to each such license agreement, the dates on
which: (a) that license agreement was entered into or otherwise became effective; (b) the Licensee Product was first provided
or made available to the licensee under that license agreement; and (c) the International Release (or any part of it) was firstmade available to the licensee under that license agreement.
7.4 The Licensee shall provide the Licensor with such information as the Licensor may reasonably request for the purpose ofverifying any statement of account submitted to the Licensor under clause 7.3 .
7.5 The Licensor shall, following receipt of a statement of account from the Licensee under clause 7.3 , submit an invoice tothe Licensee setting out the License Fees and other amounts payable by the Licensee in respect of the period to which thestatement of account relates. The Licensee shall pay to the Licensor all amounts set out on each invoice submitted under thisclause 7.5 within thirty (30) days of receipt of that invoice. The Licensee shall make payment under this clause 7.5 by wiretransfer or by such other means as the Licensor may make available to the Licensee from time to time.
7.6 Interest shall accrue on any outstanding License Fees and other amounts at the rate of the lesser of (a) 500 basis points
above the European Inter-Bank Offer Rate (EURIBOR), calculated daily from the date on which payment was due andcompounding at the end of each calendar month or (b) the maximum amount allowed under applicable law.
8. PROTECTION OF THE LICENSOR'S INTELLECTUAL PROPERTY
8.1 Nothing in this License Agreement transfers to the Licensee any right, title or interest in or to the Intellectual Property
Rights in the International Release or any part of it, or grants the Licensee any license in respect of the International Release or
any part of it except as expressly set out in clause 2 .
8.2 The Licensee shall not:8.2.1 use any trademark or service mark (or any registrations thereof) other than the Licensor's trademarks, in
any name that includes the word "SNOMED" or that is confusingly similar to SNOMED CT or any other similar
trademark;8.2.2 apply for any trade mark or service mark (or any registrations thereof) in any name that includes the word
"SNOMED", or that is confusingly similar to SNOMED, SNOMED CT or any other similar trade mark;8.2.3 abbreviate the marks SNOMED or SNOMED CT; or
8.2.4 do anything with respect to the foregoing trade marks that damages or could reasonably be deemed toreflect adversely on the Licensor or such trade marks.
8.3 The Licensee shall:
8.3.1 include the following notice on all media on which the Licensee Products are distributed and on the
documentary form of each sub-license granted by the Licensee under clause 2.1.5 :"This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of theInternational Health Terminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMEDCT®, was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" areregistered trademarks of the IHTSDO."
8.3.2 specify in all media on which any Licensee Product is distributed the version and date of the International

Release contained in the Licensee Product.
8.4 The Licensee shall be entitled to use the "SNOMED" and "SNOMED CT" trade marks only on the Licensee Products
distributed and modified in accordance with this License Agreement and any services relating thereto but not otherwise andsubject to the trade mark utilization Regulation developed by the Licensor and published by the Licensor from time to time.
All use by the Licensee of the "SNOMED" and "SNOMED CT" trade marks, and all goodwill resulting from that use, shallinure to the Licensor's benefit.
8.5 The Licensee shall maintain quality standards with respect to modifying, supplementing, marketing and distributing the
Licensee Products, and any services relating thereto, that are in accordance with applicable law and are at least as stringent as
the Regulations developed by the Licensor and published by the Licensor from time to time.
8.6 Upon reasonable written notice from the Licensor, the Licensee shall provide the Licensor with such information,
documentation and materials (including software) as are reasonably necessary to enable the Licensor to ascertain the Licensee's
compliance with its obligations under this License Agreement. In the absence of circumstances giving the Licensor reasonablegrounds to suspect a breach of this License Agreement, the Licensor may not give notice under this clause 8.6 more frequently
than once per year.
8.7 If any use of the International Release (including without limitation use through a Licensee Product) is reasonably
determined by the Licensor to be below the standards of quality required under this License Agreement, the Licensor shallnotify the Licensee of such deficiency in writing. Upon receipt of such notice, the Licensee shall take all necessary steps tocorrect such deficiency (including such steps as the Licensor may reasonably specify).
8.8 The Licensee shall maintain a complete, accurate and up-to-date register of all sub- licenses granted by the Licensee underclause 2.1.5 , and shall make that register available for inspection during normal business hours by the Licensor and its
representatives upon the Licensor giving not less than fourteen (14) days' prior written notice. The register maintained by the
Licensee under this clause 8.8 shall at a minimum contain the following information in respect of each sub-license: the nameand registered office of the sub-licensee; the Licensee Product subject to the sub-license; and the version of the International
Release included in that Licensee Product. This will enable the Licensor to:(a) verify that the Licensee has complied with this License Agreement when entering into sublicences with End
Users; and/or(b) offer support to End Users on termination of this License Agreement.
In the absence of circumstances giving the Licensor reasonable grounds to suspect a breach of this License Agreement, theLicensor may not give notice under this clause 8.8 more frequently than once per year.
9. USE IN MEMBER TERRITORIES AND NON-MEMBER TERRITORIES
9.1 The Licensee may only exercise its rights under this License Agreement in a Member Territory in accordance with suchconditions as the Member for that Member Territory may prescribe from time to time.
9.2 Conditions prescribed by a Member under clause 9.1 may:
9.2.1 include, without limitation, a requirement that the Licensee notify the Member before exercising its rights
under this License Agreement in that Member's territory and a requirement that the Licensee enter into a license
agreement with the Member in respect of that Member's National Release; and9.2.2

relate to the International Release, the Member's National Release or any part of either of them.

9.3 The Licensee shall notify the Licensor (and, if the Licensee's registered office or principal place of business is situated in a
Member Territory, shall also notify the Member for that Member Territory) in writing before exercising its rights under thisLicense Agreement in any Non-Member Territory in respect of which the Licensee has not previously given notice under thisclause 9.3 . The notice shall be in such form and manner as the Licensor may prescribe from time to time, and shall include
such information about the Licensee's current and proposed activities in that Non- Member Territory as the Licensor may
require (but the Licensor may require only the same kinds of information as it requires to be provided by new Affiliates
proposing to use, license or deploy the International Release or Licensee Products in Non-Member Territories).

9.4 In any case where the Licensee gives notice to a Member in accordance with clause 9.3 , the Licensee consents to that
Member providing the content of that notice to the Licensor.
9.5 For purposes of this clause 9 , the Licensee exercises its rights under this License Agreement in any Member Territory or
Non-Member Territory if, without limitation, it:
9.5.1 performs any act permitted by this License Agreement in that Member Territory or Non-Member Territory(as the case may be);9.5.2 deploys the International Release (or any part of it) or any Licensee Product in that Member Territory or
Non-Member Territory (as the case may be); or
9.5.3 distributes or licenses a Licensee Product for use in, or to any person who is situated in, that Member
Territory or Non-Member Territory (as the case may be).
10 AFFILIATE STATUS
10.1 During the term of this License Agreement the Licensee shall be an Affiliate.
11. REPRESENTATIONS AND WARRANTIES
11.1 To the extent permitted by law, the Licensor excludes all representations, warranties and conditions that would otherwise
be implied by law in this License Agreement (including, without limitation, all implied warranties of quality or fitness for aparticular purpose).
11.2 Without limiting clause 11.1 , the Licensor does not represent or warrant that the International Release or any part of it
will satisfy any of the Licensee's requirements, operate in combinations selected by the Licensee or be free from defects orerrors.
12. LIMITATION OF LIABILITY
12.1 The Licensor shall not be liable to the Licensee or to any other person, whether in contract, tort (including negligence),
misrepresentation, breach of statutory duty or otherwise, for any of the following arising under or in connection with thisLicense Agreement (including, without limitation, in respect of the Licensee's use of or inability to use the International
Release or any part of it):12.1.1 indirect or consequential loss;
12.1.2 special or punitive damages;
12.1.3 loss of profits, loss of savings and loss of revenue;
12.1.4 loss of business, loss of reputation and loss of goodwill; and12.1.5

loss of data.

12.2 Neither the Licensor nor any Member shall be liable to the Licensee or any other person for any failure by the Licensor or
the Member (as the case may be) to maintain or distribute any Extension (or part thereof) or Derivative transferred to the
Licensor or the Member (as the case may be) in accordance with clauses 3.4 or 3.5 .
12.3 The liability of the Licensor arising in any year under or in connection with this License Agreement, whether in contract,
tort (including negligence), misrepresentation, breach of statutory duty or otherwise, shall not in any event exceed the License
Fees paid by the Licensee in respect of that year.
12.4 Nothing in this License Agreement excludes or limits the liability of either party for:12.4.1

fraud (including fraudulent misrepresentation);

12.4.2 death or personal injury caused by the negligence of that party;

12.4.3 any breach of its obligations implied by section 12 of the Sale of Goods Act 1979; or
12.4.4 any other liability that by law cannot validly be excluded or limited (but only to the extent that theliability cannot validly be excluded or limited).
13. ASSIGNMENT
13.1 The Licensee may not assign, novate or otherwise transfer any of its rights or obligations under this License Agreement toany person without the prior written consent of the Licensor, not to be unreasonably withheld.
13.2 The Licensor may transfer all of its rights and obligations under this License Agreement to any person to whom the
Licensor transfers the Intellectual Property Rights in respect of which the licenses under this License Agreement are granted.
14. GENERAL PROVISIONS
14.1 This License Agreement contains the entire agreement between the parties relating to the subject matter of this License
Agreement, supersedes all previous agreements between the Parties relating to that subject matter and sets out the entirety of
the Licensee's rights in respect of the International Release.
14.2 Each party acknowledges that, in entering into this License Agreement, it has not relied on any representation, warranty,
collateral contract or other assurance made by or on behalf of the other party before the date of this License Agreement.
14.3 Except as provided in clause 6.3 , this License Agreement may not be varied except in writing signed by both parties andexpressed to vary this License Agreement.
14.4 Nothing in this License Agreement shall give either party the ability to act or incur obligations or liability on behalf of theother party or constitutes a joint venture, agency, partnership or employment relationship between the parties.
14.5 If any term of this License Agreement is or becomes illegal, invalid or unenforceable in any jurisdiction, that shall notaffect the legality, validity or enforceability in that jurisdiction of any other term of this License Agreement, or the legality,
validity or enforceability in any other jurisdiction of that or any other term of this License Agreement.
14.6 The Licensee agrees that the Licensor may appoint third parties to process personal data provided by the Licensee to the
Licensor under or in connection with this License Agreement (including without limitation payment details provided inconnection with the payment of License Fees). In connection with any such appointment, personal data provided by the
Licensee may be transferred to, and processed in, a country outside the United Kingdom. The laws governing the processing of
personal data may be less stringent in such a country than in the United Kingdom and the country in which the Licensee isbased.
15. GOVERNING LAW AND JURISDICTION
15.1 This License Agreement shall be governed by, and construed in accordance with, English law.
15.2 The English courts shall have exclusive jurisdiction to settle any dispute arising out of or in connection with this License
Agreement (including a dispute regarding its existence, validity or termination).
15.3 Clause 15.2 is for the benefit of the Licensor only. As a result, the Licensor shall not be prevented from taking
proceedings relating to any dispute in any other courts with jurisdiction. To the extent permitted by law, the Licensor may takeconcurrent proceedings in any number of jurisdictions.

Appendix A
Defined Terms
In this License Agreement, the following defined terms have the following meanings:

Term

Meaning

Affiliate

an affiliate of the Licensor in accordance with the Licensor’s Articles of Association;

Cross-Mapa work consisting of (i) SNOMED CT Content and (ii) content of another nomenclature, classification or
knowledge structure, together with a set of relationships between (i) and (ii);

Data
Processing
Systema computer system that is used to analyze or create records or other data that is encoded using SNOMED CT;
a work consisting of

Derivativea. SNOMED CT Content, from the SNOMED CT CORE or an Extension; together withb. either (i) additional properties and/ or information about such SNOMED CT content; and/ or ( ii) any
set of relationships between that SNOMED CT Content and content of other nomenclature,classification or knowledge structure, and includes a Cross-Map and a Sub-Set;

End Usera third party user of a Licensee Product;

Extensiona work consisting of SNOMED CT Content alone that is supplementary to the SNOMED CT Core and that
depends on the SNOMED CT Core;

Hospitala health care body or organisation providing secondary and/ or tertiary care;Intellectual
Property
Rightspatents, trade marks, service marks, copyright (including rights in computer software), moral rights, databaserights, rights in designs, trade secrets, know-how and other intellectual property rights, in each case whether
registered or unregistered and including applications for registration, and all rights or forms of protection
having equivalent or similar effect in any jurisdiction;

International the release produced and distributed by or on behalf of the Licensor, consisting of the SNOMED CT Core,
Releasethe Specifications and the Licensor’s Derivatives and other documents and software;
License Fees

the license fees set out in Appendix B (License Fees in Non- Member Territories);

Licensee
Products

products distributed or licensed by the Licensee that (1) include or interoperate with the International Release(or any part of i t) and/ or any Extensions or Derivatives created by the Licensee under this License
Agreement, or (2) read or write records or other data that is encoded using SNOMED CT;

Membera member of the Licensor;

MemberTerritory

a territory that is represented by a Member ( as published by the Licensor from time to time);

Namespace
Identifiera code or that part of a code that identifies the organization responsible for creating and maintaining aStandards-Based Extension or a Standards-Based Derivative and is used as an element of SNOMED CT
Identifiers;

National
Releasein respect of each Member, the release produced and distributed by the Member, consisting of theInternational Release, the Member’s Extensions, the Member’s Derivatives and other documents andsoftware;NonMember
Territory

a territory that is not a Member Territory;

Practice

a. a single department of a Hospital ( subject to paragraph 2. 2 of Appendix B); orderb. any health care body or organisation that provides principally primary care, including without
limitation a pharmacy, an optician’s facility, a physiotherapy centre, a general medical practice or afamily medical practice;a discrete research project that meets all of the following criteria:

Qualifying
Research
Project

a. it is supported by a formal proposal that has been peer reviewed;
b. it has been ethically approved in accordance with the prevailing legislation, regulations and guidelines
in effect in the relevant territory;c. it is conducted within a definite timeframe;d. the results of the research are offered for publication in peer-reviewed public journals and are provided
to the Licensor free of charge prior to publication;

Regulations

regulations made by the Licensor;

Relationshipa relationship, of a kind defined by the Licensor in Specifications, between concepts ( which may be, without
limitation, a hierarchical or an associative relationship) or between a concept and a description;

SNOMEDCT

the concept-based work of clinical nomenclature and classification with multiple hierarchies and semantic
definitions known as SNOMED Clinical Terms (SNOM ED CT);

SNOMEDCT Content

terminological content, consisting of concepts, descriptions and Relationships, each of which is identified
using a SNOMED CT Identifier;

SNOMEDCT Corethe SNOMED CT Content that is controlled, maintained and distributed by the Licensor from time to time;

SNOMEDCT
Identifiera code, of a kind defined by the Licensor in Specifications, for identifying concepts, descriptions andRelationships;

Specification

specifications promulgated by the Licensor for products and processing relating to SNOMED CT, including
specifications of the internal logic of SNOMED CT, editorial policies, guidelines and characteristics;

Sponsored
Territorya Non- Member Territory that has been recognized and designated by the Licensor as a sponsored territory(as published on the Licensor’s web site, www. snomed. org);

Standarda Specification that is formally adopted by the Licensor and published by the Licensor ( including by postinga copy of the Specification on a website maintained by the Licensor);StandardsBasedin respect of an Extension or a Derivative, an Extension or Derivative the creation of which is the subject of
one or more Standards; andSub- Seta sub-set of SNOMED CT Content that is grouped together for one or more purposes.

Appendix B
License Fees in Non-Member Territories
1. Introduction
1.1 This Appendix B sets out the license fees payable by the Licensee in respect of its activities in Non-Member Territories.
1.2 The license fees set out in this Appendix B do not apply in respect of the Licensee's activities in any Non-Member
Territory if that Non-Member Territory is a Sponsored Territory or was a Sponsored Territory at the time when the Licensee's
activities in that Non-Member Territory were carried out.
1.3 The Licensor may, in its sole discretion, waive the Licensee's obligation to pay any or all of the license fees set out in thisAppendix B if the Licensor considers that the Licensee's activities in any Non-Member Territory are in support of charitable or
humanitarian causes in that Non-Member Territory. Any waiver by the Licensor under this paragraph 1.3 may be revoked by
the Licensor at any time, shall be without prejudice to any of the Licensor's other rights and remedies under this License
Agreement and shall not relieve the Licensee of any of its other obligations under this License Agreement.
1.4 Beginning in 2015, license fees payable by the Licensee in respect of its activities in Non-Member Territories for eachfinancial year shall be adjusted by the same percentage as the General Assembly of the Licensor agrees to adjust the Aggregate

Annual Fee (as defined in the Licensor's Articles of Association) relative to the Aggregate Annual Fee in the previous year.
1.5 For purposes of this Appendix B, but subject to paragraph 1.6, if a Hospital or a Practice is located on multiple physicalsites, each such site shall be treated as a separate Hospital or Practice (as the case may be), and license fees shall be payable inrespect of each such separate Hospital or Practice.
1.6 The Licensor may, in its sole discretion, agree to treat multiple sites on which a Hospital or a Practice is located as a single
site for purposes of this Appendix B.
1.7 Notwithstanding anything else in this Appendix B, the deployment, distribution or licensing of any software that operates
on a mobile device of any kind (including without limitation a mobile phone or tablet device), or any software or service that isaccessed via the internet and enables users to extract or download any substantial portion of SNOMED CT, shall be treated as
falling within paragraph 4 of this Appendix B (and not within paragraph 2).
1.8 The Licensee's obligation to pay license fees in respect of any deployment of the International Release or any Licensee
Product is not dependent on that deployment of the International Release or Licensee Product being used in a live or
production environment.The Licensor may, in its sole discretion, waive the Licensee’s obligation to pay any or all of thelicense fees set out in this Appendix B in respect of any deployment of the International Release or Licensee Product in a nonproduction environment (such as a development or test environment).
1.9 In any case where the Licensee is exempt from the requirement to pay license fees by reason of a Licensee Product or a
Data Processing System being used exclusively in connection with a Qualifying Research Project, the Licensee shall report to
the Licensor on the progress of that Qualifying Research Project in such manner as the Licensor may reasonably require. The
Licensor may revoke the Licensee's exemption for Qualifying Research Projects provided in this Appendix B if the Licensee
fails to comply with this paragraph 1.9.
2. Data Processing Systems
2.1 The Licensee shall pay the following fees in respect of each Hospital or Practice in a Non-Member Territory in or to which
the Licensee:(a) deploys the International Release (or any part of it) or any Licensee Product that contains the International
Release (or any part of it) in a Data Processing System, unless that Data Processing System is used exclusively inconnection with a Qualifying Research Project; or(b) deploys, distributes or licenses a Licensee Product that is or includes a Data Processing System, unless that
Licensee Product is used exclusively in connection with a Qualifying Research Project.
Fee BandFee

Hospital in Band A Territory

US$ 1,954 per annum baseline fee adjusted as per paragraph 1.4

Hospital in Band B Territory

US$ 1,303 per annum baseline fee adjusted as per paragraph 1.4

Hospital in Band C Territory

US$ 652 per annum baseline fee adjusted as per paragraph 1.4

Practice in Band A, B or C Territory

US$ 652 per annum baseline fee adjusted as per paragraph 1.4

Hospital or Practice in Low Income Band US $0 per annum baseline fee, adjusted as per paragraph 1.4
Hospital or Practice in other territory

As per paragraph 5.2.

2.2 The total fees payable by the Licensee in respect of a number of Practices that are departments of a single Hospital shallnot exceed the fee applicable to the Hospital itself. For purposes of this Appendix B, a Practice is treated as a department of a
Hospital only if: (a) it is located on the premises of that Hospital; and (b) it is funded solely by that Hospital. In any case where
either or both of the conditions in the preceding sentence are not met in respect of any Practice, fees shall be payable in respectof that Practice in addition to any fees that are payable in respect of any Hospital.
3. [Not Used]4. Other Activities
4.1 The Licensee shall notify the Licensor in writing before deploying the International Release (or any part of it) or deploying,
distributing or licensing any Licensee Product (in each case, other than exclusively in connection with Qualifying Research
Projects) in, for use in, or to any person situated in, any Non-Member Territory in a manner that does not fall within paragraph
2 of this Appendix B, explaining the Licensee's proposed activities.
4.2 Upon receiving notice from the Licensee under this paragraph 4, the Licensor may request, and the Licensee shall provide,
such additional information in relation to the Licensee's proposed activities as the Licensor considers reasonably necessary to
determine an appropriate license and reasonable fee in respect of the Licensee's proposed activities.
4.3 The Licensee shall be liable to pay such license fees as the Licensor may determine in accordance with this paragraph 4.
5. Non-Member Territory Bandings
5.1 The allocation of a Non-Member Territory into Band A, Band B, Band C, or Low Income Band shall be as determined by
the Licensor (based on the Non-Member Territory's relative Gross National Income (GNI) or other measure adopted by the
Licensor) and published by the Licensor on its web site.
5.2 The Licensee shall notify the Licensor in writing before carrying out any activity of a kind described in paragraph 2 of thisAppendix B in a Non-Member Territory that has not been allocated by the Licensor under paragraph 5.1. Upon receiving
notice from the Licensee under this paragraph 5.2, the Licensor shall allocate the Non-Member Territory as described inparagraph 5.1.